Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	7.47e-06	5	183	3	GO:0030156
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TCF20 ANK2 SYNE1 NACA BCORL1 NSD1 GON4L BRD3 NIBAN2 WNK1 PIAS1 ZFPM2 SNAP91 BASP1 TLE1 BRD4 MDC1 SYNE2 MSL3 HSH2D PKN1 MORC3 BRD1 ZNF598 UTF1	6.01e-05	1160	183	25	GO:0030674
GeneOntologyMolecularFunction	histone reader activity	BRD4 MDC1 MSL3 BRD1	8.72e-05	26	183	4	GO:0140566
GeneOntologyMolecularFunction	cytoskeletal protein binding	EVL CACNB2 KIF6 XIRP1 ANK2 ABI3BP MYO5A MAP4 SYNE1 SPTBN1 GTSE1 APC2 PRC1 NEDD1 MAP1S SYNE2 NAV3 SNTG2 MARK2 TRAPPC14 AKAP1 TNS1 PSRC1	1.87e-04	1099	183	23	GO:0008092
GeneOntologyMolecularFunction	molecular adaptor activity	TCF20 ANK2 SYNE1 NACA BCORL1 NSD1 GON4L BRD3 NIBAN2 WNK1 PIAS1 ZFPM2 SNAP91 BASP1 TLE1 BRD4 MDC1 SYNE2 MSL3 HSH2D PKN1 MORC3 BRD1 ZNF598 AKAP1 UTF1	2.77e-04	1356	183	26	GO:0060090
GeneOntologyMolecularFunction	protein kinase binding	CACNB2 ANK2 MYO5A SRCIN1 BCAR1 PRC1 WNK1 ZFP36 CCND3 SNAP91 NFATC1 IQSEC1 PKN1 RIMS1 PLCG2 ACTL9 TBR1 MAP3K7 AKAP1	4.33e-04	873	183	19	GO:0019901
GeneOntologyMolecularFunction	protein domain specific binding	EVL CACNB2 MYO5A DTNA SRCIN1 BCAR1 FOXA1 PIAS1 NKD1 SYNJ1 SNAP91 EGR2 ZNF592 BASP1 ARHGAP31 SNTG2 RIMS1 SRRM2 UTF1	4.45e-04	875	183	19	GO:0019904
GeneOntologyMolecularFunction	chromatin-protein adaptor activity	BRD4 MDC1 MSL3 BRD1	5.30e-04	41	183	4	GO:0140463
GeneOntologyMolecularFunction	kinase binding	CACNB2 ANK2 MYO5A SRCIN1 BCAR1 PRC1 WNK1 ZFP36 CCND3 SNAP91 NFATC1 IQSEC1 PKN1 IGSF9B RIMS1 PLCG2 ACTL9 TBR1 MAP3K7 AKAP1	5.97e-04	969	183	20	GO:0019900
GeneOntologyMolecularFunction	cytoskeleton-nuclear membrane anchor activity	SYNE1 SYNE2	8.20e-04	5	183	2	GO:0140444
GeneOntologyBiologicalProcess	neuron projection morphogenesis	EVL ABI3BP SYNE1 APBB2 SRCIN1 NIBAN2 TTC3 ANOS1 CELSR3 MAP1S SNAP91 EGR2 NFIB CNTN5 ARHGAP44 ROBO2 RIMS1 ACTL9 MARK2 TBR1 CTNND2 PARD3 NYAP1	6.73e-07	802	182	23	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	EVL ABI3BP SYNE1 APBB2 SRCIN1 NIBAN2 TTC3 ANOS1 CELSR3 MAP1S SNAP91 EGR2 NFIB CNTN5 ARHGAP44 ROBO2 RIMS1 ACTL9 MARK2 TBR1 CTNND2 PARD3 NYAP1	9.65e-07	819	182	23	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	EVL ABI3BP SYNE1 APBB2 SRCIN1 NIBAN2 TTC3 ANOS1 CELSR3 MAP1S SNAP91 EGR2 NFIB CNTN5 ARHGAP44 ROBO2 RIMS1 ACTL9 MARK2 TBR1 CTNND2 PARD3 NYAP1	1.12e-06	826	182	23	GO:0048858
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	EVL ABI3BP SYNE1 APBB2 SRCIN1 NIBAN2 TTC3 ANOS1 CELSR3 MAP1S SNAP91 EGR2 NFIB CNTN5 ARHGAP44 ROBO2 ACTL9 MARK2 TBR1 CTNND2 PARD3	2.98e-06	748	182	21	GO:0048667
GeneOntologyBiologicalProcess	axonogenesis	EVL APBB2 NIBAN2 TTC3 ANOS1 CELSR3 MAP1S SNAP91 EGR2 NFIB CNTN5 ROBO2 ACTL9 MARK2 TBR1 PARD3	4.42e-05	566	182	16	GO:0007409
GeneOntologyBiologicalProcess	neuron projection development	EVL ABI3BP MAP4 SYNE1 APBB2 SRCIN1 NIBAN2 TTC3 ANOS1 CELSR3 MAP1S AMIGO3 SNAP91 EGR2 NFIB CNTN5 ARHGAP44 IQSEC1 ROBO2 RIMS1 ACTL9 MARK2 TBR1 CTNND2 PARD3 NYAP1	6.40e-05	1285	182	26	GO:0031175
GeneOntologyBiologicalProcess	telomeric D-loop disassembly	TERF2 BLM SLX4	7.75e-05	10	182	3	GO:0061820
GeneOntologyBiologicalProcess	mitotic cell cycle	INCENP MAP4 SPTBN1 GTSE1 PRC1 NEDD1 FOXA1 WNK1 PIAS1 BAP1 CCND3 BLM IGF2 MAP1S NFATC1 NFIB CDC16 BRD4 MDC1 MKI67 LSM14A PSRC1	9.11e-05	1014	182	22	GO:0000278
GeneOntologyBiologicalProcess	telomeric loop disassembly	TERF2 BLM SLX4	1.06e-04	11	182	3	GO:0090657
GeneOntologyBiologicalProcess	cell morphogenesis	EVL ABI3BP SYNE1 APBB2 SRCIN1 NIBAN2 TTC3 BAP1 ANOS1 CELSR3 MAP1S SNAP91 EGR2 NFIB CNTN5 ARHGAP44 ROBO2 RIMS1 ACTL9 MARK2 TBR1 CTNND2 PARD3 NYAP1	1.39e-04	1194	182	24	GO:0000902
GeneOntologyBiologicalProcess	axon development	EVL APBB2 NIBAN2 TTC3 ANOS1 CELSR3 MAP1S SNAP91 EGR2 NFIB CNTN5 ROBO2 ACTL9 MARK2 TBR1 PARD3	1.90e-04	642	182	16	GO:0061564
GeneOntologyBiologicalProcess	mitotic cell cycle process	INCENP MAP4 SPTBN1 GTSE1 PRC1 WNK1 PIAS1 CCND3 BLM IGF2 MAP1S NFATC1 NFIB CDC16 BRD4 MDC1 MKI67 LSM14A PSRC1	2.05e-04	854	182	19	GO:1903047
GeneOntologyBiologicalProcess	neuron development	EVL ABI3BP MAP4 SYNE1 APBB2 SRCIN1 NIBAN2 TTC3 WNK1 ANOS1 CELSR3 MAP1S AMIGO3 SNAP91 EGR2 NFIB CNTN5 ARHGAP44 IQSEC1 ROBO2 RIMS1 ACTL9 MARK2 TBR1 CTNND2 PARD3 NYAP1	2.10e-04	1463	182	27	GO:0048666
GeneOntologyBiologicalProcess	anterograde trans-synaptic signaling	CACNB2 MYO5A DTNA SYNE1 WNK1 CHRNA4 RIMBP3 RIN1 SNCAIP SYNJ1 SNAP91 EGR2 ARHGAP44 IQSEC1 KMT2A RIMBP3C IGSF9B RIMS1 CTNND2 RIMBP3B	2.21e-04	931	182	20	GO:0098916
GeneOntologyBiologicalProcess	chemical synaptic transmission	CACNB2 MYO5A DTNA SYNE1 WNK1 CHRNA4 RIMBP3 RIN1 SNCAIP SYNJ1 SNAP91 EGR2 ARHGAP44 IQSEC1 KMT2A RIMBP3C IGSF9B RIMS1 CTNND2 RIMBP3B	2.21e-04	931	182	20	GO:0007268
GeneOntologyBiologicalProcess	axon guidance	EVL APBB2 NIBAN2 ANOS1 CELSR3 EGR2 NFIB CNTN5 ROBO2 TBR1	2.30e-04	285	182	10	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	EVL APBB2 NIBAN2 ANOS1 CELSR3 EGR2 NFIB CNTN5 ROBO2 TBR1	2.37e-04	286	182	10	GO:0097485
GeneOntologyBiologicalProcess	trans-synaptic signaling	CACNB2 MYO5A DTNA SYNE1 WNK1 CHRNA4 RIMBP3 RIN1 SNCAIP SYNJ1 SNAP91 EGR2 ARHGAP44 IQSEC1 KMT2A RIMBP3C IGSF9B RIMS1 CTNND2 RIMBP3B	2.47e-04	939	182	20	GO:0099537
GeneOntologyBiologicalProcess	neuromuscular synaptic transmission	DTNA RIMBP3 RIMBP3C RIMBP3B	2.77e-04	36	182	4	GO:0007274
GeneOntologyBiologicalProcess	telomere maintenance via telomere trimming	TERF2 BLM SLX4	2.84e-04	15	182	3	GO:0090737
GeneOntologyBiologicalProcess	t-circle formation	TERF2 BLM SLX4	2.84e-04	15	182	3	GO:0090656
GeneOntologyBiologicalProcess	formation of extrachromosomal circular DNA	TERF2 BLM SLX4	2.84e-04	15	182	3	GO:0001325
GeneOntologyBiologicalProcess	protein depolymerization	EVL SPTBN1 APC2 NEDD1 MAP1S SYNJ1 NAV3	2.95e-04	144	182	7	GO:0051261
GeneOntologyCellularComponent	postsynaptic specialization	ANK2 ABI3BP MAP4 SPTBN1 SRCIN1 CHRNA4 CELSR3 SNAP91 ARHGAP44 IQSEC1 ROBO2 PLEKHA5 IGSF9B RIMS1 CTNND2 MAP3K7 AKAP1	1.91e-06	503	181	17	GO:0099572
GeneOntologyCellularComponent	postsynaptic density	ANK2 ABI3BP MAP4 SPTBN1 SRCIN1 CELSR3 SNAP91 ARHGAP44 IQSEC1 ROBO2 PLEKHA5 IGSF9B RIMS1 CTNND2 MAP3K7	9.54e-06	451	181	15	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	ANK2 ABI3BP MAP4 SPTBN1 SRCIN1 CELSR3 SNAP91 ARHGAP44 IQSEC1 ROBO2 PLEKHA5 IGSF9B RIMS1 CTNND2 MAP3K7	1.84e-05	477	181	15	GO:0032279
GeneOntologyCellularComponent	postsynapse	ANK2 ABI3BP MYO5A MAP4 SYNE1 SPTBN1 APC2 SRCIN1 MAGEE1 PIAS1 CHRNA4 CELSR3 SNAP91 ARHGAP44 IQSEC1 ROBO2 PLEKHA5 IGSF9B RIMS1 MARK2 CTNND2 MAP3K7 AKAP1	2.50e-05	1018	181	23	GO:0098794
GeneOntologyCellularComponent	cell leading edge	EVL ABI3BP MYO5A SPTBN1 APC2 APBB2 SRCIN1 BCAR1 ARHGAP31 ARHGAP44 SYNE2 ANGPTL3 ROBO2 PLCG2 RASGRP2	3.18e-05	500	181	15	GO:0031252
GeneOntologyCellularComponent	neuron to neuron synapse	ANK2 ABI3BP MAP4 SPTBN1 SRCIN1 CELSR3 SNAP91 ARHGAP44 IQSEC1 ROBO2 PLEKHA5 IGSF9B RIMS1 CTNND2 MAP3K7	5.30e-05	523	181	15	GO:0098984
GeneOntologyCellularComponent	lamellipodium	EVL ABI3BP APC2 APBB2 SRCIN1 BCAR1 ARHGAP31 SYNE2 ANGPTL3	1.85e-04	230	181	9	GO:0030027
GeneOntologyCellularComponent	axon	MYO5A MAP4 DTNA SPTBN1 APBB2 ADGRL1 SRCIN1 BCAR1 TERF2 SYNJ1 SNAP91 BASP1 NFIB CNTN5 NAV1 ROBO2 WDFY3 ACTL9 PARD3	2.76e-04	891	181	19	GO:0030424
GeneOntologyCellularComponent	PR-DUB complex	BAP1 ASXL2	4.42e-04	4	181	2	GO:0035517
GeneOntologyCellularComponent	lateral element	INCENP BLM SYCP1	5.59e-04	19	181	3	GO:0000800
GeneOntologyCellularComponent	synaptic membrane	ANK2 SYNE1 ADGRL1 MAGEE1 CHRNA4 SNCAIP CELSR3 SYNJ1 SNAP91 CNTN5 ROBO2 IGSF9B RIMS1 AKAP1	5.76e-04	583	181	14	GO:0097060
GeneOntologyCellularComponent	synaptonemal complex	INCENP BLM LIG3 SYCP1	6.68e-04	46	181	4	GO:0000795
GeneOntologyCellularComponent	synaptonemal structure	INCENP BLM LIG3 SYCP1	6.68e-04	46	181	4	GO:0099086
GeneOntologyCellularComponent	spindle	INCENP MAP4 PRC1 NEDD1 WNK1 MAP7D1 MAP1S CDC16 LSM14A TRAPPC14 PARD3 PSRC1	8.56e-04	471	181	12	GO:0005819
GeneOntologyCellularComponent	male germ cell nucleus	KIF6 TERF2 ZFPM2 BLM SYCP1	9.10e-04	86	181	5	GO:0001673
GeneOntologyCellularComponent	PcG protein complex	PCGF2 BAP1 UBAP2L ASXL2	1.06e-03	52	181	4	GO:0031519
GeneOntologyCellularComponent	condensed nuclear chromosome	INCENP BLM LIG3 BRD4 SYCP1	1.17e-03	91	181	5	GO:0000794
GeneOntologyCellularComponent	cytoplasmic stress granule	LARP1 ZFP36 UBAP2L PRRC2C LSM14A	1.49e-03	96	181	5	GO:0010494
GeneOntologyCellularComponent	manchette	RIMBP3 RIMBP3C RIMBP3B	1.78e-03	28	181	3	GO:0002177
GeneOntologyCellularComponent	mitotic spindle	MAP4 PRC1 WNK1 MAP1S CDC16 LSM14A TRAPPC14	1.88e-03	201	181	7	GO:0072686
GeneOntologyCellularComponent	central element	INCENP SYCP1	2.02e-03	8	181	2	GO:0000801
GeneOntologyCellularComponent	nuclear body	PCGF2 FYTTD1 TCF20 INCENP GON4L TERF2 PIAS1 BLM SBF1 NFATC1 BASP1 MDC1 MKI67 WDFY3 MORC3 BRD1 SRRM2	2.24e-03	903	181	17	GO:0016604
GeneOntologyCellularComponent	M band	MYBPH ANK2 SPTBN1	2.40e-03	31	181	3	GO:0031430
GeneOntologyCellularComponent	leading edge membrane	SPTBN1 APC2 ARHGAP44 SYNE2 ROBO2 PLCG2 RASGRP2	2.41e-03	210	181	7	GO:0031256
HumanPheno	Attention deficit hyperactivity disorder	PCGF2 SPTBN1 APC2 BCORL1 NSD1 ADGRL1 CHRNA4 BAP1 IGF2 SYNJ1 UBAP2L NFIB BRD4 IQSEC1 PACS2 DEPDC5 TRAPPC14 SRRM2 RAI1	4.60e-07	413	65	19	HP:0007018
HumanPheno	Hyperactivity	PCGF2 HIVEP2 TCF20 SPTBN1 APC2 BCORL1 NSD1 ADGRL1 CHRNA4 BAP1 IGF2 SYNJ1 UBAP2L NFIB BRD4 IQSEC1 KMT2A PACS2 DEPDC5 TRAPPC14 SRRM2 RAI1	6.38e-07	558	65	22	HP:0000752
HumanPheno	Short attention span	PCGF2 SYNE1 SPTBN1 APC2 BCORL1 NSD1 ADGRL1 CHRNA4 BAP1 IGF2 SYNJ1 UBAP2L NFIB BRD4 IQSEC1 KMT2A PACS2 DEPDC5 TRAPPC14 SRRM2 RAI1	7.72e-07	517	65	21	HP:0000736
HumanPheno	Reduced attention regulation	PCGF2 SYNE1 SPTBN1 APC2 BCORL1 NSD1 ADGRL1 CHRNA4 BAP1 IGF2 SYNJ1 UBAP2L NFIB BRD4 IQSEC1 KMT2A PACS2 DEPDC5 TRAPPC14 SRRM2 RAI1	1.03e-06	526	65	21	HP:5200044
HumanPheno	Slanting of the palpebral fissure	PCGF2 HIVEP2 ADAMTS3 SPTBN1 APC2 BCORL1 NSD1 BAP1 SYNJ1 UBAP2L NFIB BRD4 MSL3 KMT2A PACS2 TBR1 CTNND2 TRAPPC14 MAP3K7 EIF2AK3 SLX4 RAI1	6.60e-05	739	65	22	HP:0200006
Domain	FN3	MYBPH ABI3BP SPEG RIMBP3 ANOS1 PTPRB CNTN5 ROBO2 RIMBP3C IGSF9B RIMBP3B	3.75e-06	199	180	11	PS50853
Domain	FN3_dom	MYBPH ABI3BP SPEG RIMBP3 ANOS1 PTPRB CNTN5 ROBO2 RIMBP3C IGSF9B RIMBP3B	6.00e-06	209	180	11	IPR003961
Domain	FN3	MYBPH ABI3BP SPEG ANOS1 PTPRB CNTN5 ROBO2 RIMBP3C IGSF9B RIMBP3B	1.27e-05	185	180	10	SM00060
Domain	EPHD	TCF20 KMT2A BRD1 RAI1	5.33e-05	22	180	4	PS51805
Domain	PH_dom-like	EVL SPTBN1 APBB2 ARHGEF12 NIBAN2 SBF1 OSBPL3 PLCH2 IQSEC1 PLEKHA5 SNTG2 PLCG2 WDFY3 TNS1	6.86e-05	426	180	14	IPR011993
Domain	PH	TEX2 SPTBN1 ARHGEF12 NIBAN2 SBF1 OSBPL3 PLCH2 IQSEC1 PLEKHA5 SNTG2 PLCG2	8.35e-05	278	180	11	SM00233
Domain	PH_domain	TEX2 SPTBN1 ARHGEF12 NIBAN2 SBF1 OSBPL3 PLCH2 IQSEC1 PLEKHA5 SNTG2 PLCG2	8.90e-05	280	180	11	IPR001849
Domain	AIP3_C	SRCIN1 KIAA1217	9.24e-05	2	180	2	IPR022782
Domain	AIP3	SRCIN1 KIAA1217	9.24e-05	2	180	2	PF03915
Domain	GTSE1_N	GTSE1 PSRC1	9.24e-05	2	180	2	IPR032768
Domain	GTSE1_N	GTSE1 PSRC1	9.24e-05	2	180	2	PF15259
Domain	DDA3/GTSE-1	GTSE1 PSRC1	9.24e-05	2	180	2	IPR026657
Domain	fn3	MYBPH ABI3BP SPEG ANOS1 PTPRB CNTN5 ROBO2 IGSF9B	1.78e-04	162	180	8	PF00041
Domain	Niban-like	NIBAN1 NIBAN2	2.75e-04	3	180	2	IPR026088
Domain	uDENN	DENND2A SBF1 DENND4B	2.96e-04	14	180	3	SM00800
Domain	ZF_PHD_2	TCF20 NSD1 KMT2A ASXL2 BRD1 RAI1	3.15e-04	95	180	6	PS50016
Domain	ZF_PHD_1	TCF20 NSD1 KMT2A ASXL2 BRD1 RAI1	3.33e-04	96	180	6	PS01359
Domain	uDENN	DENND2A SBF1 DENND4B	3.68e-04	15	180	3	PF03456
Domain	PH_DOMAIN	SPTBN1 ARHGEF12 NIBAN2 SBF1 OSBPL3 PLCH2 IQSEC1 PLEKHA5 SNTG2 PLCG2	3.87e-04	279	180	10	PS50003
Domain	CH	SYNE1 SPTBN1 SYNE2 NAV3 NAV2	4.07e-04	65	180	5	SM00033
Domain	-	EVL SPTBN1 APBB2 ARHGEF12 NIBAN2 SBF1 OSBPL3 PLCH2 IQSEC1 PLEKHA5 PLCG2 TNS1	4.24e-04	391	180	12	2.30.29.30
Domain	DENN	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	SM00799
Domain	DENN	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	PF02141
Domain	dDENN	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	PF03455
Domain	UDENN	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	PS50946
Domain	DDENN	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	PS50947
Domain	dDENN	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	SM00801
Domain	dDENN_dom	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	IPR005112
Domain	uDENN_dom	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	IPR005113
Domain	DENN	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	PS50211
Domain	DENN_dom	DENND2A SBF1 DENND4B	4.49e-04	16	180	3	IPR001194
Domain	BET	BRD3 BRD4	5.47e-04	4	180	2	PF17035
Domain	KASH	SYNE1 SYNE2	5.47e-04	4	180	2	IPR012315
Domain	KASH	SYNE1 SYNE2	5.47e-04	4	180	2	PS51049
Domain	KASH	SYNE1 SYNE2	5.47e-04	4	180	2	SM01249
Domain	KASH	SYNE1 SYNE2	5.47e-04	4	180	2	PF10541
Domain	NET_dom	BRD3 BRD4	5.47e-04	4	180	2	IPR027353
Domain	NET	BRD3 BRD4	5.47e-04	4	180	2	PS51525
Domain	CH	SYNE1 SPTBN1 SYNE2 NAV3 NAV2	5.74e-04	70	180	5	PF00307
Domain	-	SYNE1 SPTBN1 SYNE2 NAV3 NAV2	6.12e-04	71	180	5	1.10.418.10
Domain	BROMODOMAIN_2	BRD3 BRD4 KMT2A BRD1	6.40e-04	41	180	4	PS50014
Domain	CH	SYNE1 SPTBN1 SYNE2 NAV3 NAV2	6.96e-04	73	180	5	PS50021
Domain	Bromodomain	BRD3 BRD4 KMT2A BRD1	7.02e-04	42	180	4	IPR001487
Domain	BROMO	BRD3 BRD4 KMT2A BRD1	7.02e-04	42	180	4	SM00297
Domain	-	BRD3 BRD4 KMT2A BRD1	7.02e-04	42	180	4	1.20.920.10
Domain	CH-domain	SYNE1 SPTBN1 SYNE2 NAV3 NAV2	7.87e-04	75	180	5	IPR001715
Domain	Spectrin	SYNE1 SPTBN1 SYNE2	1.35e-03	23	180	3	PF00435
Domain	ACTININ_2	SYNE1 SPTBN1 SYNE2	1.35e-03	23	180	3	PS00020
Domain	ACTININ_1	SYNE1 SPTBN1 SYNE2	1.35e-03	23	180	3	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 SPTBN1 SYNE2	1.35e-03	23	180	3	IPR001589
Domain	PHD	TCF20 NSD1 KMT2A BRD1 RAI1	1.70e-03	89	180	5	SM00249
Domain	Znf_PHD	TCF20 NSD1 KMT2A BRD1 RAI1	1.87e-03	91	180	5	IPR001965
Domain	Bromodomain_CS	BRD3 BRD4 BRD1	1.94e-03	26	180	3	IPR018359
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP2 TCF20 MAP4 TEX2 SPTBN1 GTSE1 C19orf47 LARP1 BCAR1 WNK1 KIAA1671 NHSL1 MAP7D1 MAST4 SBF1 SYNJ1 OSBPL3 PRRC2C KIAA1217 BRD4 SYNE2 IQSEC1 NAV2 NAV1 KMT2A PLEKHA5 BOD1L1 MARK2 MORC3 BRD1 TRAPPC14 PATJ PARD3 ZNF598 SRRM2 AKAP1	6.43e-22	861	185	36	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNB2 TCF20 ANK2 MYO5A PRR36 WDR7 SYNE1 SPTBN1 APC2 NSD1 ARHGEF12 TTC3 CCDC177 MAP7D1 SBF1 SYNJ1 SNAP91 BASP1 UBAP2L OSBPL3 PRRC2C KIAA1217 ARHGAP44 SYNE2 IQSEC1 NAV1 PLEKHA5 PKN1 RIMS1 WDFY3 CTNND2 PARD3 TNS1 RAI1	1.87e-18	963	185	34	28671696
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EVL TCF20 MAP4 SPTBN1 GTSE1 TATDN2 LARP1 BRD3 NIBAN2 TERF2 BAP1 BLM MAP1S ZNF592 UBAP2L BRD4 MDC1 MSL3 MKI67 IQSEC1 KMT2A PACS2 PKN1 RIMS1 MARK2 PARD3 SRRM2 AKAP1 PRG4	1.68e-16	774	185	29	15302935
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EVL CACNB2 ZNF609 HIVEP2 FYTTD1 MYO5A MAP4 DTNA APBB2 LARP1 ADGRL1 SRCIN1 BCAR1 NEDD1 TTC3 CCND3 KIAA1671 TNRC18 IGF2 PTPRB NFATC1 UBAP2L NFIB KIAA1217 ARHGAP44 NAV1 SNTG2 PKN1 BOD1L1 LSM14A IGSF9B RIMS1 PATJ PARD3 RAI1 LRRC41 MGRN1	3.80e-15	1489	185	37	28611215
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ANK2 MYO5A MAP4 WDR7 TEX2 SPTBN1 ADGRL1 SRCIN1 RIN1 SYNJ1 SNAP91 BASP1 UBAP2L IQSEC1 RIMS1 MARK2 CTNND2 TRAPPC14 SRRM2 MAP3K7	3.89e-15	347	185	20	17114649
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	EVL DENND2A CACNB2 ANK2 MYO5A PRR36 MAP4 WDR7 SYNE1 SPTBN1 ARHGEF12 LARP1 ADGRL1 SRCIN1 CCDC177 NHSL1 RIN1 MAP7D1 MAP1S SBF1 SYNJ1 SNAP91 UBAP2L PRRC2C KIAA1217 VCAN ARHGAP44 IQSEC1 NAV1 KMT2A PACS2 PLEKHA5 RIMS1 MARK2 CTNND2 TNS1	6.56e-15	1431	185	36	37142655
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ZNF609 GTSE1 APC2 BCAR1 MAGEE1 POM121C WNK1 PIAS1 KIAA1671 ZNF469 TNRC18 MAP1S EGR2 ARHGAP31 PLCH2 MDC1 HSH2D IGSF9B PATJ NYAP1 MGRN1	2.03e-14	430	185	21	35044719
Pubmed	Human transcription factor protein interaction networks.	ZNF609 TCF20 MYO5A DTNA POLH SPTBN1 NACA BCORL1 NUP88 LARP1 GON4L FOXA1 POM121C PIAS1 ZFPM2 BAP1 BLM KIAA1671 LIG3 MAP7D1 ZNF592 BASP1 UBAP2L NFIB PRRC2C TLE1 MDC1 SYNE2 MKI67 KMT2A LSM14A ASXL2 TBR1 SRRM2 SLX4	3.62e-14	1429	185	35	35140242
Pubmed	Interaction network of human early embryonic transcription factors.	ZNF609 HIVEP2 TCF20 BCORL1 NUP88 POM121C PIAS1 KIAA1671 LIG3 TNRC18 EGR2 NFIB TLE1 MDC1 MKI67 KMT2A ASXL2 SLX4 RAI1	6.04e-14	351	185	19	38297188
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DENND2A ZNF609 TEX2 NACA LARP1 SRCIN1 BAP1 MAST4 CELSR3 SBF1 AMIGO3 ZNF592 ARHGAP31 PLCH2 MDC1 NAV2 ROBO2 PLEKHA5 DEPDC5 RAI1 MGRN1	1.10e-12	529	185	21	14621295
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIVEP2 SPEG MEX3D GTSE1 C19orf47 NSD1 ADGRL1 TTC3 POM121C WNK1 BAP1 CCND3 NHSL1 TNRC18 CELSR3 MAP1S ZBED4 SBF1 SYNJ1 NFATC1 ZNF592 BRD4 ARHGAP44 NAV2 NAV1 PKN1 DEPDC5 WDFY3 RAI1	1.39e-12	1105	185	29	35748872
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	MAP4 GTSE1 NUP88 LARP1 NIBAN2 BCAR1 PRC1 WNK1 TERF2 BLM RIN1 UBAP2L CDC16 MKI67 NAV2 PLEKHA5 PKN1 MARK2 SRRM2 PSRC1	3.82e-12	503	185	20	16964243
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TCF20 WDR7 SYNE1 SPEG ARHGEF12 GON4L ADGRL1 MAP7D1 ZBED4 UBAP2L PRRC2C DENND4B NAV3 NAV1 PACS2 BOD1L1 ASXL2 SRRM2	8.40e-12	407	185	18	12693553
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	TCF20 INCENP POLH BCORL1 NSD1 BRD3 PIAS1 BAP1 BLM LIG3 SBNO1 ZNF592 BRD4 MDC1 MKI67 KMT2A BOD1L1 MORC3 BRD1 RAI1 LRRC41	1.51e-11	608	185	21	36089195
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	EVL ANK2 MYO5A MAP4 TEX2 DTNA SPTBN1 NACA NUP88 ADGRL1 SRCIN1 CRIP2 NHSL1 TNRC18 MAP1S SYNJ1 BASP1 UBAP2L PRRC2C CDC16 KIAA1217 IQSEC1 NAV3 NAV1 RIMS1 CTNND2 MAP3K7	8.77e-11	1139	185	27	36417873
Pubmed	A human MAP kinase interactome.	HIVEP2 TCF20 ABI3BP SYNE1 SPTBN1 ADGRL1 MUC12 POM121C WNK1 PIAS1 ZC3H7A ARHGAP31 NAV3 NAV2 NAV1 PLEKHA5 MAP3K7 TNS1	1.52e-10	486	185	18	20936779
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DTNA BCORL1 C19orf47 BCAR1 WNK1 PIAS1 RIMBP3 BLM KIAA1671 ZC3H7A SYNJ1 NFATC1 PRRC2C KIAA1217 NAV1 MORC3 PATJ SLX4	3.10e-09	588	185	18	38580884
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ANK2 MAP4 NACA NUP88 LARP1 NIBAN2 NEDD1 POM121C WNK1 KIAA1671 LIG3 SYNJ1 UBAP2L PRRC2C KIAA1217 MKI67 KMT2A BOD1L1 LSM14A PRR14L ZNF598 AKAP1	6.31e-09	934	185	22	33916271
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ZNF609 FYTTD1 TCF20 BCORL1 NUP88 NSD1 BRD3 PRC1 POM121C TERF2 BAP1 BLM LIG3 MAP7D1 ZBED4 NFIB OSBPL3 CDC16 BRD4 MDC1 MSL3 MKI67 KMT2A ASXL2 SRRM2 RAI1	6.41e-09	1294	185	26	30804502
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TCF20 MAP4 NSD1 LARP1 KIAA1671 SYNJ1 UBAP2L PRRC2C CDC16 BRD4 MDC1 KMT2A PLEKHA5 BOD1L1 PATJ PARD3 ZNF598	7.32e-09	549	185	17	38280479
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	FYTTD1 MYO5A MAP4 SYNE1 NACA NSD1 ARHGEF12 GON4L BRD3 TERF2 PIAS1 BLM KIAA1671 ZC3H7A MAP7D1 SBF1 ZNF592 NFIB CDC16 MDC1 KMT2A LSM14A MARK2 CTNND2 PATJ PARD3 ZNF598 AKAP1	7.43e-09	1497	185	28	31527615
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF609 TCF20 POLH BCORL1 NUP88 BAP1 KIAA1671 MAP7D1 SYNJ1 ZNF592 TLE1 BRD4 NAV1 PLEKHA5 AKAP1	8.34e-09	418	185	15	34709266
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF609 TCF20 INCENP MAP4 POLH GTSE1 BCORL1 NSD1 LARP1 BLM LIG3 SNAP91 UBAP2L PRRC2C BRD4 MDC1 MKI67 KMT2A BOD1L1 SRRM2 SLX4 RAI1	9.23e-09	954	185	22	36373674
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	GARIN5B EVL ANK2 ABI3BP MYO5A DTNA SYNE1 SPTBN1 LARP1 BRD3 TTC3 TERF2 ZC3H7A TNRC18 MAP7D1 ZBED4 SNAP91 SBNO1 PRRC2C SYNE2 SYCP1 NAV2 KMT2A BOD1L1 LSM14A RIMS1 RAI1	1.39e-08	1442	185	27	35575683
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TCF20 INCENP MYO5A MAP4 SPTBN1 NUP88 NSD1 LARP1 BLM SBF1 UBAP2L PRRC2C MDC1 SYNE2 MKI67 KMT2A SRRM2 RAI1	1.56e-08	653	185	18	22586326
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	TCF20 MAP4 NUP88 LARP1 CCDC168 POM121C PRRC2C MDC1 SYNE2	2.19e-08	123	185	9	26912792
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZNF609 TCF20 POLH FOXA1 BAP1 TNRC18 NFIB TLE1 BRD4 MDC1 KMT2A RAI1	2.45e-08	268	185	12	33640491
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	FYTTD1 INCENP MYO5A MAP4 NACA C19orf47 LARP1 PRC1 TERF2 BLM ZC3H7A LIG3 UBAP2L PRRC2C MKI67 LSM14A MARK2 AKAP1 EFCAB7	2.81e-08	759	185	19	35915203
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ZNF609 TCF20 BCORL1 LARP1 GON4L BRD3 ZFPM2 LIG3 TNRC18 SYNJ1 NFIB TLE1 BRD4 SYNE2	3.42e-08	398	185	14	35016035
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	CACNB2 ANK2 MYO5A WDR7 SYNE1 SPTBN1 SRCIN1 SYNJ1 BASP1 IQSEC1 RIMS1 CTNND2	4.13e-08	281	185	12	28706196
Pubmed	The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.	CDCA3 INCENP PRC1 CCND3 NFATC1 EGR2 MKI67 PLCG2 EIF2AK3 RASGRP2 MUC20	4.27e-08	227	185	11	26410627
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	ZNF609 INCENP SYNE1 NACA NUP88 LARP1 NIBAN2 PRC1 NEDD1 TERF2 BAP1 BLM MAP7D1 MAP1S CDC16 MSL3 SYCP1 MKI67 LSM14A ASXL2 MARK2 MORC3 SLX4	6.10e-08	1155	185	23	20360068
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	CACNB2 FYTTD1 DTNA APBB2 ADGRL1 NIBAN2 NHSL1 SBF1 KIAA1217 DENND4B ROBO2 PLEKHA5 MARK2 PARD3	6.83e-08	421	185	14	36976175
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	CDCA3 MAP4 SPTBN1 ARHGEF12 LARP1 SRCIN1 NIBAN2 KIAA1671 NHSL1 SYNJ1 KIAA1217 NAV2 PLEKHA5 MARK2 PATJ PARD3	7.05e-08	565	185	16	25468996
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	INCENP BCORL1 GON4L BRD3 PRC1 WNK1 TERF2 LIG3 ZNF592 UBAP2L MSL3 NAV1 KMT2A MORC3 BRD1 MAP3K7 RAI1	7.57e-08	645	185	17	25281560
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYBPH ANK2 DTNA SYNE1 SPTBN1 GON4L TTC3 WNK1 MAP7D1 ZNF592 SYNE2 HEY2 PARD3 MAP3K7 AKAP1	8.10e-08	497	185	15	23414517
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CACNB2 FYTTD1 MAP4 TEX2 SPTBN1 NSD1 TTC3 WNK1 TUB TCP11L2 SYNJ1 UBAP2L OSBPL3 VCAN BOD1L1 BIN2 ASXL2 PATJ PARD3 ANKRD40 TNS1 SLX4	8.72e-08	1084	185	22	11544199
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	MAP4 SPTBN1 NACA ARHGEF12 SRCIN1 AGPS SNAP91 NFIB PKN1 CTNND2 SRRM2	9.67e-08	246	185	11	15345747
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	NUP88 LARP1 AGPS PRC1 POM121C BLM SBF1 ZNF592 UBAP2L CDC16 MDC1 MKI67 EIF2AK3 SLX4	1.17e-07	440	185	14	34244565
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	MAP4 GTSE1 PRC1 SYNJ1 CDC16 PLEKHA5 SRRM2 PSRC1	1.23e-07	108	185	8	19531213
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12 MUC20	1.48e-07	3	185	3	26770020
Pubmed	Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans.	NAV3 NAV2 NAV1	1.48e-07	3	185	3	12079279
Pubmed	Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53.	NAV3 NAV2 NAV1	1.48e-07	3	185	3	15158073
Pubmed	Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms.	NAV3 NAV2 NAV1	1.48e-07	3	185	3	12062803
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CDCA3 ZNF609 MYO5A DTNA SPTBN1 BRD3 NIBAN2 BCAR1 TERF2 BLM KIAA1671 NHSL1 CNNM1 PTPRB SBF1 BASP1 SYNE2 MKI67 SRRM2 MAP3K7 TNS1	2.19e-07	1049	185	21	27880917
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	TCF20 SPTBN1 GON4L BRD3 TERF2 BLM LIG3 BASP1 CDC16 BRD4 MDC1 KMT2A RAI1	2.23e-07	394	185	13	27248496
Pubmed	The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.	POM121C PRRC2C MDC1 MKI67 SRRM2	4.32e-07	29	185	5	17577209
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ZNF609 NACA LARP1 GON4L PIAS1 LIG3 MAP7D1 SBF1 OSBPL3 PRRC2C KMT2A PLEKHA5 MARK2 PATJ LRRC41 MGRN1	4.61e-07	650	185	16	38777146
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	EVL ZNF609 TCF20 MAP4 BCORL1 LARP1 PRC1 NEDD1 PIAS1 TNRC18 MAP7D1 PRRC2C BRD4 MKI67 KMT2A LSM14A BIN2 ASXL2 SRRM2 RAI1 RASGRP2	4.96e-07	1103	185	21	34189442
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	SPEG SPTBN1 BRD3 SRCIN1 BLM MAP7D1 PTPRB MAP1S ZNF592 NAV2 KMT2A PLEKHA5 MARK2 RAI1	5.08e-07	497	185	14	36774506
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	GARIN5B XIRP1 TCF20 SYNE1 MAGEE1 MAP7D1 UBAP2L MKI67 IQSEC1 SRRM2	5.46e-07	233	185	10	37704626
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	5.90e-07	4	185	3	19091768
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	ZNF609 MYO5A GTSE1 NUP88 LARP1 AGPS NEDD1 ZC3H7A MAP7D1 SBNO1 UBAP2L TLE1 BRD4 PLEKHA5 MARK2 ZNF598 LRRC41	6.72e-07	754	185	17	33060197
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	XIRP1 BCORL1 SRCIN1 TERF2 NHSL1 TNRC18 SBF1 SYNJ1 NFATC1 NFIB OSBPL3 DENND4B ROBO2 RIMBP3C ASXL2 TBR1	9.90e-07	689	185	16	36543142
Pubmed	rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions.	MYO5A MAP4 GTSE1 PRC1 PIAS1 CCND3 NAV1 MARK2	1.01e-06	142	185	8	30217970
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	TCF20 BRD3 ZNF592 BRD4 MKI67 KMT2A RAI1	1.39e-06	103	185	7	32744500
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	1.47e-06	5	185	3	17855024
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ZNF609 ADAMTS3 ARHGEF12 WNK1 MAST4 RIMS1 SRRM2	1.48e-06	104	185	7	9205841
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PCGF2 HIVEP2 ANK2 MYO5A SYNE1 SPTBN1 APC2 APBB2 TTC3 PIAS1 ZFP36 CELSR3 MAP1S SYNJ1 SBNO1 ZNF592 NAV3 WDFY3 MORC3 CTNND2 HERPUD2 SLX4	1.51e-06	1285	185	22	35914814
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	DENND2A ANK2 MAP4 SPTBN1 SRCIN1 CTNND2	1.59e-06	67	185	6	29254152
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TEX2 SPTBN1 ARHGEF12 NEDD1 CCDC177 TUB SYNJ1 UBAP2L PRRC2C NAV3 LSM14A IGSF9B PARD3	1.80e-06	475	185	13	31040226
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	SPTBN1 GTSE1 NSD1 LARP1 BCAR1 TTC3 TNRC18 ZBED4 SBF1 PRRC2C NAV1	1.87e-06	332	185	11	37433992
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF609 TCF20 TEX2 NACA LARP1 NEDD1 WNK1 ZC3H7A TLE1 MDC1 NAV1 PLEKHA5 BOD1L1 PRR14L PATJ AKAP1	2.20e-06	733	185	16	34672954
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	BCORL1 LARP1 BRD3 AGPS KIAA1671 LIG3 ZBED4 ZNF592 BASP1 DENND4B BOD1L1 IGSF9B TBR1 PRG4 SERPINA9 RAI1	2.32e-06	736	185	16	29676528
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	MAP4 LARP1 BRD3 TTC3 CHRNA4 CRIP2 IGF2 SNCAIP SBF1 TLE1 BRD4 SYNE2 MKI67 ROBO2 PKN1 CTNND2 MAP3K7 TNS1 PSRC1 RAI1	2.64e-06	1124	185	20	21900206
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	EVL MEX3D SRCIN1 NHSL1 SNCAIP CTNND2 ZNF598 MAP3K7 NYAP1	2.80e-06	218	185	9	33378226
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TCF20 INCENP MYO5A MAP4 SPTBN1 NACA AGPS BLM ZC3H7A RIN1 LIG3 MAP7D1 SBF1 MDC1 MKI67 IQSEC1 PLEKHA5 PRR14L PLCG2 WDFY3 PARD3 SRRM2	3.48e-06	1353	185	22	29467282
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	FYTTD1 MEX3D LARP1 CCND3 SYNJ1 NFIB MDC1 SYNE2 MKI67 PARD3 SRRM2	3.85e-06	358	185	11	32460013
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	SPTBN1 NACA LARP1 LIG3 SNCAIP PTPRB PRRC2C KIAA1217 PLEKHA5 LSM14A SRRM2	4.06e-06	360	185	11	33111431
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MAP4 ARHGEF12 MAP7D1 CELSR3 MAP1S ZNF592 PRRC2C MDC1 PLEKHA5 CTNND2 SRRM2	4.17e-06	361	185	11	26167880
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MYO5A SPEG SPTBN1 SRCIN1 IQSEC1 RIMS1 MARK2 CTNND2 SRRM2	4.49e-06	231	185	9	16452087
Pubmed	A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.	NUP88 LARP1 AGPS ZC3H7A MAP7D1 SBNO1 UBAP2L TLE1 BRD4 PLEKHA5	4.96e-06	298	185	10	32353859
Pubmed	Dynamic microtubules catalyze formation of navigator-TRIO complexes to regulate neurite extension.	NAV3 NAV2 NAV1	5.10e-06	7	185	3	25065758
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ZNF609 MAP4 GTSE1 LARP1 NIBAN2 NEDD1 PIAS1 BLM LIG3 SBNO1 UBAP2L SLX4	5.16e-06	444	185	12	34795231
Pubmed	MPP3 is required for maintenance of the apical junctional complex, neuronal migration, and stratification in the developing cortex.	MKI67 TBR1 PATJ PARD3	5.26e-06	22	185	4	23658188
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ZNF609 TCF20 POM121C PIAS1 NFIB MARK2 PATJ RAI1	5.90e-06	180	185	8	35198878
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ANK2 MAP4 DTNA SPTBN1 ARHGEF12 LARP1 NIBAN2 UBAP2L PRRC2C PLEKHA5 BOD1L1 MARK2 PATJ PARD3 EIF2AK3	6.59e-06	708	185	15	39231216
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	MAP4 ADGRL1 PTPRB UBAP2L PLCG2 PARD3 SRRM2	7.61e-06	133	185	7	15144186
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ZNF609 NUP88 LARP1 NEDD1 POM121C WNK1 BLM KIAA1671 RIN1 SOWAHA SBNO1 IGHA2 OSBPL3 CDC16 ARHGAP44 NAV1 PLEKHA5 MARK2 MORC3 TBR1 PARD3	8.30e-06	1321	185	21	27173435
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ZNF609 MYO5A MAP4 LARP1 NIBAN2 PRC1 TTC3 ZC3H7A MAP7D1 SBF1 BASP1 UBAP2L PRRC2C MKI67 ZNF598	8.59e-06	724	185	15	36232890
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	CACNB2 ANK2 MYO5A SYNE1 SPTBN1 SYNJ1 BASP1 IQSEC1 CTNND2	8.77e-06	251	185	9	27507650
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TCF20 INCENP MAP4 BRD3 PRC1 PIAS1 BLM LIG3 SBNO1 ZNF592 NFIB TLE1 CDC16 BRD4 MDC1 MKI67 KMT2A BOD1L1	8.86e-06	1014	185	18	32416067
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF609 BRD3 FOXA1 POM121C KIAA1671 ZNF469 MAP7D1 SOWAHA ZNF592 OSBPL3 CDC16 BRD4 IQSEC1 WDFY3 BRD1 PARD3 SRRM2 RAI1 LRRC41	8.89e-06	1116	185	19	31753913
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	FYTTD1 MYO5A PRR36 DTNA NACA ARHGEF12 PRC1 KIAA1671 MAP7D1 ARHGAP31 UBAP2L ARHGAP44 KMT2A LSM14A PATJ MAP3K7 AKAP1	8.99e-06	916	185	17	32203420
Pubmed	Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.	MAP4 TEX2 LARP1 POM121C SYNE2 MKI67 PLEKHA5 EIF2AK3	9.11e-06	191	185	8	31177093
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	MAP4 POLH GTSE1 NACA LARP1 BASP1 UBAP2L PRRC2C PLEKHA5	1.03e-05	256	185	9	33397691
Pubmed	Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.	MAP4 LARP1 UBAP2L PRRC2C MKI67	1.03e-05	54	185	5	25631074
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	ANK2 MAP4 BCAR1 LIG3 CELSR3 BRD4 MKI67 RIMS1 PLCG2 PRG4	1.17e-05	329	185	10	17474147
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	SPTBN1 ADGRL1 TUB CNNM1 BASP1 PLCH2 DENND4B NAV3 ROBO2 MARK2 CTNND2	1.23e-05	405	185	11	38187761
Pubmed	Rhombomere-specific analysis reveals the repertoire of genetic cues expressed across the developing hindbrain.	TUB CELSR3 EGR2 TNS1	1.24e-05	27	185	4	19208226
Pubmed	SCML2 establishes the male germline epigenome through regulation of histone H2A ubiquitination.	PCGF2 MDC1 SYCP1 SRRM2	1.24e-05	27	185	4	25703348
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	CDCA3 MAP4 TEX2 SPTBN1 LARP1 NIBAN2 BASP1 UBAP2L PRRC2C SYNE2 PRR14L AKAP1 EIF2AK3	1.24e-05	568	185	13	37774976
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	CDCA3 TCF20 NEDD1 POM121C KIAA1671 KIAA1217 MKI67 PLEKHA5 PARD3	1.27e-05	263	185	9	34702444
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	GTSE1 NEDD1 MAP1S PLEKHA5 MARK2	1.35e-05	57	185	5	29089450
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	NIBAN1 ABI3BP WDR7 ROBO2 RIMS1 CTNND2 HERPUD2 PARD3 TNS1	1.35e-05	265	185	9	19240061
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	INCENP MYO5A MAP4 SPTBN1 NACA LARP1 PRC1 KIAA1671 MAP7D1 PRRC2C CDC16 KIAA1217 MDC1 MKI67 NAV1 PLEKHA5 LSM14A MARK2 PATJ ZNF598	1.36e-05	1257	185	20	36526897
Pubmed	Tagging genes with cassette-exchange sites.	WDR7 GTSE1 ARHGEF12 LARP1 SBNO1 NFIB PRRC2C MKI67 NAV2 TNS1	1.37e-05	335	185	10	15741177
Pubmed	Loss of BAF (mSWI/SNF) chromatin-remodeling ATPase Brg1 causes multiple malformations of cortical development in mice.	MKI67 ROBO2 TBR1 PARD3	1.44e-05	28	185	4	35666215
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	ANK2 SPTBN1 MKI67	1.73e-05	10	185	3	22159418
Pubmed	ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.	BAP1 BRD4 ASXL2	1.73e-05	10	185	3	32669118
Interaction	YWHAH interactions	HIVEP2 TCF20 TEX2 SPEG MEX3D SPTBN1 GTSE1 C19orf47 LARP1 BCAR1 WNK1 CHRNA4 ZFP36 BAP1 KIAA1671 NHSL1 RIN1 MAP7D1 SNCAIP MAST4 SBF1 SYNJ1 BASP1 OSBPL3 PRRC2C KIAA1217 BRD4 SYNE2 NAV2 NAV1 KMT2A PACS2 PLEKHA5 BOD1L1 RIMS1 MARK2 MORC3 BRD1 TRAPPC14 PATJ PARD3 SRRM2 MAP3K7 AKAP1	4.86e-17	1102	184	44	int:YWHAH
Interaction	YWHAZ interactions	EVL HIVEP2 MYO5A WDR7 TEX2 SPEG SPTBN1 LARP1 BRD3 BCAR1 WNK1 PIAS1 BAP1 KIAA1671 NHSL1 RIN1 MAP7D1 MAST4 SBF1 IGHA2 OSBPL3 BRD4 MDC1 SYNE2 NAV2 NAV1 KMT2A PACS2 PLEKHA5 DEPDC5 PRR14L ASXL2 WDFY3 MARK2 MORC3 BRD1 PARD3 ZNF598 ANKRD40 TNS1	1.20e-11	1319	184	40	int:YWHAZ
Interaction	YWHAG interactions	HIVEP2 SPEG SPTBN1 GTSE1 C19orf47 LARP1 BCAR1 PRC1 WNK1 PIAS1 ZFP36 BAP1 KIAA1671 NHSL1 RIN1 MAP7D1 MAST4 SBF1 SYNJ1 OSBPL3 PRRC2C SYNE2 IQSEC1 NAV2 NAV1 KMT2A PACS2 PLEKHA5 BOD1L1 MARK2 MORC3 BRD1 TRAPPC14 PATJ PARD3 SRRM2 EFCAB7	1.57e-10	1248	184	37	int:YWHAG
Interaction	NUP43 interactions	ZNF609 TCF20 INCENP MAP4 POLH NUP88 NSD1 LARP1 GON4L CCDC168 PRC1 POM121C TERF2 BLM LIG3 ZNF592 PRRC2C MDC1 SYNE2 MKI67 KMT2A BOD1L1 ASXL2 SRRM2 SLX4	5.81e-10	625	184	25	int:NUP43
Interaction	TOP3B interactions	HIVEP2 SPEG MEX3D GTSE1 C19orf47 NSD1 ADGRL1 NEDD1 TTC3 POM121C WNK1 ZFP36 BAP1 CCND3 NHSL1 ZC3H7A LIG3 ANOS1 TNRC18 CELSR3 MAP1S ZBED4 SBF1 SYNJ1 NFATC1 ZNF592 UBAP2L BRD4 ARHGAP44 MDC1 NAV2 NAV1 PKN1 DEPDC5 LSM14A WDFY3 KLHL14 ZNF598 RAI1	1.15e-09	1470	184	39	int:TOP3B
Interaction	H2BC8 interactions	TCF20 INCENP BCORL1 NSD1 GON4L BRD3 PRC1 TERF2 PIAS1 BLM LIG3 SBNO1 ZNF592 NFIB BRD4 MDC1 MSL3 MKI67 KMT2A MORC3 BRD1 RAI1 LRRC41	3.11e-09	576	184	23	int:H2BC8
Interaction	H3C1 interactions	GARIN5B ANK2 INCENP SYNE1 NACA NSD1 LARP1 BRD3 PRC1 FOXA1 PIAS1 BLM LIG3 TNRC18 MAP7D1 BASP1 PRRC2C CDC16 BRD4 MDC1 MSL3 MKI67 NAV3 NAV2 KMT2A BIN2 PRR14L MORC3 BRD1	3.27e-09	901	184	29	int:H3C1
Interaction	MAPRE3 interactions	MAP4 GTSE1 APC2 NEDD1 KIAA1671 MAP7D1 MAST4 MAP1S KIAA1217 NAV2 NAV1 PLEKHA5 MARK2 ZNF598 PSRC1	3.33e-09	230	184	15	int:MAPRE3
Interaction	TRIM36 interactions	MAP4 GTSE1 PRC1 NEDD1 ZC3H7A MAP7D1 MAST4 MAP1S NAV1 PLEKHA5 MARK2 PSRC1	8.51e-09	144	184	12	int:TRIM36
Interaction	MAPRE1 interactions	SPTBN1 GTSE1 APC2 NUP88 LARP1 BAP1 MAP7D1 MAST4 MAP1S PRRC2C KIAA1217 BRD4 NAV3 NAV2 NAV1 PLEKHA5 LSM14A BRD1 ZNF598 SRRM2 PSRC1	1.07e-08	514	184	21	int:MAPRE1
Interaction	KCTD13 interactions	EVL DENND2A CACNB2 ANK2 MYO5A PRR36 MAP4 WDR7 SYNE1 SPTBN1 ARHGEF12 LARP1 ADGRL1 SRCIN1 CCDC177 NHSL1 RIN1 MAP7D1 MAP1S SBF1 SYNJ1 SNAP91 UBAP2L PRRC2C KIAA1217 VCAN ARHGAP44 IQSEC1 NAV1 KMT2A PACS2 PLEKHA5 RIMS1 MARK2 CTNND2 TNS1	1.15e-08	1394	184	36	int:KCTD13
Interaction	TLE3 interactions	ZNF609 HIVEP2 TCF20 POLH BCORL1 FOXA1 PIAS1 BAP1 TNRC18 EGR2 NFIB TLE1 BRD4 KMT2A ASXL2 TBR1 SRRM2 ANKRD40	1.15e-08	376	184	18	int:TLE3
Interaction	SH3KBP1 interactions	DENND2A MAP4 GGN GTSE1 BCAR1 PRC1 ZFP36 TNRC18 SYNJ1 CDC16 ARHGAP44 MDC1 PLEKHA5 PATJ SRRM2 PSRC1	3.44e-08	315	184	16	int:SH3KBP1
Interaction	SFN interactions	MAP4 TEX2 SPTBN1 LARP1 BCAR1 WNK1 PIAS1 ZFP36 BAP1 KIAA1671 MAP7D1 MAST4 NFIB OSBPL3 PRRC2C NAV2 NAV1 KMT2A PACS2 PLEKHA5 MARK2 PARD3 SRRM2	9.18e-08	692	184	23	int:SFN
Interaction	H3C3 interactions	TCF20 INCENP BCORL1 NSD1 BRD3 PIAS1 BAP1 BLM LIG3 SBNO1 BRD4 MDC1 MKI67 KMT2A BOD1L1 MORC3 BRD1 RAI1 LRRC41	1.48e-07	495	184	19	int:H3C3
Interaction	TERF2IP interactions	ZNF609 TCF20 INCENP NSD1 TERF2 PIAS1 BAP1 BLM LIG3 SBNO1 ZNF592 BRD4 MDC1 MKI67 KMT2A BOD1L1 WDFY3 SRRM2 SLX4 RAI1	1.73e-07	552	184	20	int:TERF2IP
Interaction	BAG2 interactions	ZNF609 TCF20 TEX2 BCORL1 BRD3 PRC1 NEDD1 FOXA1 WNK1 BAP1 KIAA1671 PRRC2C BRD4 MDC1 BOD1L1 PRR14L BRD1 ZNF598 SRRM2 MAP3K7 AKAP1	2.69e-07	622	184	21	int:BAG2
Interaction	YWHAE interactions	HIVEP2 GTSE1 LARP1 SRCIN1 BCAR1 PRC1 TTC3 WNK1 BAP1 KIAA1671 RIN1 MAP7D1 MAST4 SBF1 OSBPL3 BRD4 NAV2 NAV1 KMT2A PACS2 PLEKHA5 DEPDC5 ASXL2 MARK2 MORC3 BRD1 PARD3 ZNF598 SRRM2 MAP3K7 EFCAB7	3.82e-07	1256	184	31	int:YWHAE
Interaction	FMR1 interactions	CACNB2 TCF20 SPTBN1 APC2 LARP1 PRC1 ZFPM2 ZC3H7A UBAP2L PRRC2C KIAA1217 BRD4 MKI67 IQSEC1 LSM14A WDFY3 PARD3 ZNF598 TNS1	4.99e-07	536	184	19	int:FMR1
Interaction	PEX5L interactions	ANK2 MYO5A WDR7 SPTBN1 KIAA1217 CTNND2 PARD3	5.82e-07	54	184	7	int:PEX5L
Interaction	EPB41L4A interactions	DTNA SPTBN1 NIBAN2 BASP1 KIAA1217 MSL3 PLEKHA5 MARK2 PATJ PARD3	6.48e-07	140	184	10	int:EPB41L4A
Interaction	ALG13 interactions	ZNF609 TCF20 ZFP36 ZC3H7A UBAP2L PRRC2C TLE1 CDC16 LSM14A WDFY3 AKAP1	9.93e-07	183	184	11	int:ALG13
Interaction	PFN1 interactions	EVL ANK2 MYO5A TEX2 SPTBN1 ARHGEF12 WNK1 BAP1 KIAA1671 NHSL1 SYNJ1 BASP1 TLE1 KIAA1217 SYNE2 NAV1 PLEKHA5 BOD1L1	1.05e-06	509	184	18	int:PFN1
Interaction	LCK interactions	CDCA3 MYO5A DTNA SPTBN1 NIBAN2 BCAR1 TUB KIAA1671 SYNJ1 BASP1 KIAA1217 NAV1 PLEKHA5 PLCG2 MARK2 CTNND2 PARD3	1.27e-06	463	184	17	int:LCK
Interaction	GSK3B interactions	MAP4 TEX2 NACA ARHGEF12 NIBAN2 BCAR1 PRC1 PIAS1 KIAA1671 NHSL1 SNCAIP MAST4 NFATC1 BASP1 PRRC2C TLE1 MKI67 PLEKHA5 MARK2 CTNND2 ZNF598 MAP3K7 SLX4 RAI1	1.32e-06	868	184	24	int:GSK3B
Interaction	FLOT1 interactions	CDCA3 PCGF2 ANK2 INCENP DTNA SPTBN1 ARHGEF12 NIBAN2 BCAR1 PRC1 BASP1 KIAA1217 PLEKHA5 BOD1L1 MARK2 PATJ PARD3	1.80e-06	475	184	17	int:FLOT1
Interaction	HMGN3 interactions	BRD3 PRC1 TERF2 PIAS1 PRRC2C BRD4 MSL3	1.89e-06	64	184	7	int:HMGN3
Interaction	CBX3 interactions	PCGF2 TCF20 INCENP BCORL1 NSD1 BRD3 PRC1 PIAS1 BAP1 BLM LIG3 SBNO1 BRD4 MDC1 MKI67 KMT2A ASXL2 BRD1 SRRM2 SLX4	2.01e-06	646	184	20	int:CBX3
Interaction	KDM6A interactions	FOXA1 BAP1 EGR2 NFIB TLE1 BRD4 KMT2A BOD1L1 ASXL2 TBR1	2.46e-06	162	184	10	int:KDM6A
Interaction	MEX3A interactions	SPTBN1 GTSE1 NSD1 LARP1 BCAR1 TTC3 ZFP36 ZC3H7A TNRC18 ZBED4 SBF1 UBAP2L PRRC2C NAV1 LSM14A	2.60e-06	384	184	15	int:MEX3A
Interaction	MARF1 interactions	GTSE1 POM121C TERF2 ZFP36 KIAA1671 ZC3H7A SOWAHA UBAP2L LSM14A	2.72e-06	128	184	9	int:MARF1
Interaction	DCTN1 interactions	PRR36 MAP4 SPTBN1 GTSE1 NACA PRC1 NEDD1 BAP1 ZC3H7A MAP7D1 MAP1S KIAA1217 NAV1 PLEKHA5 MARK2 ZNF598 PSRC1	3.31e-06	497	184	17	int:DCTN1
Interaction	H3-3A interactions	TCF20 INCENP POLH BCORL1 NSD1 BRD3 NIBAN2 PIAS1 BLM LIG3 SBNO1 ZNF592 BRD4 MDC1 MKI67 KMT2A BOD1L1 MORC3 BRD1 RAI1 LRRC41	5.18e-06	749	184	21	int:H3-3A
Interaction	YWHAB interactions	SPEG SPTBN1 LARP1 BCAR1 FOXA1 WNK1 ZFP36 BAP1 KIAA1671 NHSL1 RIN1 MAP7D1 MAST4 BASP1 OSBPL3 NAV2 NAV1 KMT2A PACS2 PLEKHA5 MARK2 MORC3 BRD1 PARD3 SRRM2	5.98e-06	1014	184	25	int:YWHAB
Interaction	CHAMP1 interactions	BRD3 BCAR1 PRC1 TERF2 NFATC1 BRD4 MDC1 MKI67 SLX4	8.94e-06	148	184	9	int:CHAMP1
Interaction	SOX7 interactions	ZNF609 TCF20 BCORL1 ZFPM2 TNRC18 NFIB TLE1	1.01e-05	82	184	7	int:SOX7
Interaction	YWHAQ interactions	HIVEP2 MAP4 SPEG GTSE1 C19orf47 LARP1 BCAR1 WNK1 ZFP36 BAP1 KIAA1671 NHSL1 MAP7D1 MAST4 SBF1 NFATC1 OSBPL3 BRD4 NAV2 NAV1 KMT2A PACS2 PLEKHA5 MARK2 BRD1 PARD3	1.08e-05	1118	184	26	int:YWHAQ
Interaction	AFDN interactions	CDCA3 DTNA NIBAN2 BAP1 KIAA1671 RIN1 BASP1 KIAA1217 KMT2A PLEKHA5 MARK2 PATJ PARD3	1.24e-05	333	184	13	int:AFDN
Interaction	AR interactions	ZNF609 TCF20 MYO5A POLH NSD1 LARP1 BRD3 FOXA1 PIAS1 BAP1 LIG3 TNRC18 UBAP2L NFIB TLE1 KIAA1217 BRD4 MDC1 KMT2A HSH2D PLCG2 MORC3 TNS1 RAI1	1.28e-05	992	184	24	int:AR
Interaction	APEX1 interactions	CDCA3 FYTTD1 TCF20 INCENP MYO5A SPTBN1 BCORL1 NSD1 BRD3 BCAR1 TTC3 TERF2 BAP1 BLM LIG3 MAP7D1 BASP1 BRD4 MSL3 KMT2A LSM14A MARK2 ZNF598 MAP3K7 PSRC1 RAI1 LRRC41 MGRN1	1.30e-05	1271	184	28	int:APEX1
Interaction	SHANK3 interactions	TCF20 ANK2 MYO5A MAP4 SYNE1 SPTBN1 NACA NUP88 ADGRL1 PRC1 MAP1S SYNJ1 SNAP91 BASP1 ARHGAP44 IQSEC1	1.35e-05	496	184	16	int:SHANK3
Interaction	KIF2A interactions	MAP4 SPTBN1 GTSE1 BRD3 PRC1 MAP7D1 MAP1S BRD4 ROBO2 PLEKHA5 SLX4	1.46e-05	242	184	11	int:KIF2A
Interaction	SMC5 interactions	ZNF609 TCF20 INCENP MAP4 POLH GTSE1 BCORL1 NSD1 LARP1 BCAR1 TERF2 BLM LIG3 SNAP91 UBAP2L PRRC2C BRD4 MDC1 MKI67 KMT2A BOD1L1 SRRM2 SLX4 RAI1	1.46e-05	1000	184	24	int:SMC5
Interaction	HMG20A interactions	ZNF609 TCF20 DTNA GON4L BRD3 RIN1 BASP1 NFIB BRD4 TBR1 RAI1	1.57e-05	244	184	11	int:HMG20A
Interaction	NUP50 interactions	TCF20 NACA NSD1 NIBAN2 BLM SOWAHA SBNO1 BRD4 KMT2A BOD1L1 SRRM2 SLX4 RAI1	1.60e-05	341	184	13	int:NUP50
Interaction	SIRT7 interactions	TCF20 INCENP MYO5A MAP4 POLH SPTBN1 NUP88 NSD1 LARP1 BLM SBF1 UBAP2L PRRC2C BRD4 MDC1 SYNE2 MKI67 KMT2A SRRM2 RAI1	1.62e-05	744	184	20	int:SIRT7
Interaction	HCFC1 interactions	BAP1 EGR2 UBAP2L PRRC2C BRD4 MKI67 KMT2A BOD1L1 ASXL2 MAP3K7 NYAP1 SLX4	1.68e-05	293	184	12	int:HCFC1
Interaction	EIF4E2 interactions	LARP1 BCAR1 FOXA1 ZFP36 ZC3H7A UBAP2L CDC16 NAV1 PLEKHA5 ASXL2 ZNF598	1.70e-05	246	184	11	int:EIF4E2
Interaction	PHF21A interactions	POLH BCORL1 NUP88 BAP1 KIAA1671 MAP7D1 SYNJ1 EGR2 ZNF592 BRD4 NAV1 PLEKHA5 AKAP1	1.70e-05	343	184	13	int:PHF21A
Interaction	SOX5 interactions	ZNF609 TCF20 EGR2 NFIB PRRC2C TLE1 LSM14A TBR1 ANKRD40	1.85e-05	162	184	9	int:SOX5
Interaction	TAOK2 interactions	MAP4 TEX2 SRCIN1 BASP1 UBAP2L IQSEC1 NAV1 CTNND2 MAP3K7	2.04e-05	164	184	9	int:TAOK2
Interaction	PNMA2 interactions	FYTTD1 MYO5A GTSE1 POM121C MAP7D1 SBF1 PLEKHA5 RIMBP3C BRD1 PARD3 SLX4	2.04e-05	251	184	11	int:PNMA2
Interaction	BCOR interactions	ZNF609 PCGF2 BCORL1 BAP1 EGR2 UBAP2L NFIB CDC16 BRD4 TBR1 BRD1 SLX4	2.27e-05	302	184	12	int:BCOR
Interaction	GARRE1 interactions	AGPS BCAR1 ZFP36 KIAA1671 ZC3H7A UBAP2L LSM14A MARK2 BRD1	2.35e-05	167	184	9	int:GARRE1
Interaction	SARNP interactions	XIRP1 FYTTD1 SYNE1 BRD3 CRIP2 BAP1 BRD4 LSM14A SRRM2	2.47e-05	168	184	9	int:SARNP
Interaction	CDH1 interactions	CDCA3 MAP4 SPTBN1 ARHGEF12 LARP1 SRCIN1 NIBAN2 BCAR1 KIAA1671 NHSL1 SYNJ1 EGR2 KIAA1217 MKI67 NAV2 PLEKHA5 MARK2 CTNND2 PATJ PARD3	2.55e-05	768	184	20	int:CDH1
Interaction	PAXIP1 interactions	LARP1 FOXA1 PIAS1 BLM EGR2 NFIB CDC16 MDC1 KMT2A BOD1L1 TBR1 SRRM2 SLX4	2.73e-05	359	184	13	int:PAXIP1
Interaction	KALRN interactions	ANK2 MYO5A SPTBN1 SNCAIP IQSEC1 MORC3 CTNND2	2.84e-05	96	184	7	int:KALRN
Interaction	NAA40 interactions	ANK2 MAP4 NACA NUP88 LARP1 NIBAN2 NEDD1 FOXA1 POM121C WNK1 KIAA1671 LIG3 SYNJ1 UBAP2L PRRC2C KIAA1217 MKI67 KMT2A BOD1L1 LSM14A PRR14L ZNF598 AKAP1	3.07e-05	978	184	23	int:NAA40
Interaction	SUMO2 interactions	MAP4 SPTBN1 NACA BRD3 NIBAN2 PRC1 PIAS1 BLM BASP1 UBAP2L BRD4 MDC1 MKI67 BOD1L1 MORC3 SRRM2 SLX4	3.12e-05	591	184	17	int:SUMO2
Interaction	KMT2C interactions	FOXA1 BAP1 EGR2 NFIB KMT2A BOD1L1 ASXL2 TBR1	3.25e-05	134	184	8	int:KMT2C
Interaction	H2AX interactions	NACA GON4L BRD3 BCAR1 PRC1 FOXA1 TERF2 PIAS1 TUB BLM LIG3 TNRC18 ZNF592 MDC1 MKI67 BRD1 SRRM2	3.26e-05	593	184	17	int:H2AX
Interaction	KIF20A interactions	ANK2 INCENP SYNE1 POLH SPTBN1 APC2 LARP1 ADGRL1 PRC1 BLM KIAA1671 BASP1 UBAP2L BRD4 MDC1 SYNE2 MKI67 NAV3 NAV2 BOD1L1 PLCG2 TBR1 PARD3 SRRM2	3.31e-05	1052	184	24	int:KIF20A
Interaction	SPTBN1 interactions	ANK2 ABI3BP MYO5A SPTBN1 LARP1 PRC1 TTC3 PIAS1 BAP1 SYNE2 NAV2 PLEKHA5 ZNF598 SRRM2	3.42e-05	421	184	14	int:SPTBN1
Interaction	LYN interactions	CDCA3 EVL ANK2 INCENP DTNA SPTBN1 ADGRL1 NIBAN2 BCAR1 BASP1 KIAA1217 KMT2A ROBO2 PLEKHA5 IGSF9B PLCG2 MARK2 PARD3 SRRM2	3.44e-05	720	184	19	int:LYN
Interaction	HMGN2 interactions	SYNE1 BRD3 BCAR1 PRC1 WNK1 TERF2 PIAS1 BRD4 MDC1 ASXL2	3.88e-05	222	184	10	int:HMGN2
Interaction	ERG interactions	ZNF609 TCF20 MYO5A BRD3 PIAS1 NFIB TLE1 BRD4 ASXL2 SLX4	4.03e-05	223	184	10	int:ERG
Interaction	FXR2 interactions	EVL GTSE1 PRC1 TERF2 BAP1 KIAA1671 ZC3H7A UBAP2L PRRC2C KIAA1217 BRD4 MKI67 LSM14A ZNF598	4.30e-05	430	184	14	int:FXR2
Interaction	PML interactions	ZNF609 MAP4 GTSE1 LARP1 NIBAN2 NEDD1 TERF2 PIAS1 BLM LIG3 MAP1S NFATC1 SBNO1 UBAP2L CDC16 BRD4 MDC1 SYNE2 KMT2A MORC3 BRD1 SLX4	4.44e-05	933	184	22	int:PML
Interaction	POLR1G interactions	TCF20 INCENP BCORL1 NSD1 BRD3 FOXA1 BAP1 BLM LIG3 SBNO1 ZNF592 BRD4 KMT2A SRRM2 RAI1	4.51e-05	489	184	15	int:POLR1G
Interaction	DMD interactions	DTNA SYNE1 BCAR1 TERF2 SYNE2 SNTG2 MARK2 TNS1	4.67e-05	141	184	8	int:DMD
Interaction	CTNNB1 interactions	ANK2 DTNA APC2 SRCIN1 BCAR1 PRC1 BAP1 KIAA1671 NHSL1 LIG3 EGR2 TLE1 KIAA1217 BRD4 SYNE2 MKI67 KMT2A PLEKHA5 PKN1 ASXL2 CTNND2 PARD3 SRRM2	4.96e-05	1009	184	23	int:CTNNB1
Interaction	ATN1 interactions	ZNF609 FOXA1 TERF2 CRIP2 MAP7D1 EGR2 TLE1 KMT2A CTNND2	5.70e-05	187	184	9	int:ATN1
Interaction	PHLPP1 interactions	MAP4 POLH GTSE1 NACA LARP1 BASP1 UBAP2L PRRC2C KIAA1217 PLEKHA5 PROB1 MARK2	5.86e-05	333	184	12	int:PHLPP1
Interaction	HERC2 interactions	ANK2 MAP4 SPTBN1 GTSE1 NSD1 ARHGEF12 TTC3 BLM MAP7D1 BRD4 MDC1 SYNE2 PRR14L MARK2 RAI1	6.20e-05	503	184	15	int:HERC2
Interaction	H2AC4 interactions	TCF20 POLH SPTBN1 GON4L BCAR1 PRC1 TERF2 BAP1 BLM LIG3 CDC16 BRD4 KMT2A SLX4 RAI1	6.63e-05	506	184	15	int:H2AC4
Interaction	SIRT6 interactions	NUP88 LARP1 AGPS PRC1 POM121C PIAS1 BLM CELSR3 SBF1 ZNF592 UBAP2L CDC16 BRD4 MDC1 MKI67 EIF2AK3 SLX4	6.63e-05	628	184	17	int:SIRT6
Interaction	WDR5 interactions	MAP4 SPTBN1 NACA NUP88 LARP1 PRC1 FOXA1 TERF2 CRIP2 BAP1 MAP7D1 SBF1 EGR2 UBAP2L PRRC2C BRD4 IQSEC1 KMT2A PKN1 BOD1L1 ASXL2 MAP3K7 TNS1 SLX4	6.78e-05	1101	184	24	int:WDR5
Interaction	EN1 interactions	ZNF609 BAP1 NFIB TLE1 KMT2A ASXL2 SRRM2	6.80e-05	110	184	7	int:EN1
Interaction	RBBP5 interactions	INCENP BLM MAP1S EGR2 BRD4 MKI67 KMT2A PKN1 BOD1L1 TBR1 SRRM2	6.92e-05	287	184	11	int:RBBP5
Interaction	CDC42 interactions	CDCA3 MAP4 SYNE1 SPTBN1 GTSE1 ARHGEF12 ADGRL1 MUC12 NIBAN2 BCAR1 WNK1 CRIP2 BAP1 SBF1 SBNO1 BASP1 ARHGAP31 BRD4 ARHGAP44 SYNE2 MKI67 PLEKHA5 LSM14A PLCG2 MARK2 PARD3 EIF2AK3	7.06e-05	1323	184	27	int:CDC42
Interaction	H2BC21 interactions	PCGF2 TCF20 INCENP BCORL1 NSD1 TERF2 BLM LIG3 CDC16 BRD4 MDC1 MSL3 MKI67 KMT2A BRD1 SRRM2 VWA5B1 RAI1	7.22e-05	696	184	18	int:H2BC21
Interaction	RPA4 interactions	MAP4 SPTBN1 NACA LARP1 PRC1 BLM KIAA1671 LIG3 PRRC2C MKI67 PARD3 MAP3K7 AKAP1 SLX4	7.33e-05	452	184	14	int:RPA4
Interaction	HDAC1 interactions	ZNF609 TCF20 POLH NUP88 GON4L ZFP36 ZFPM2 BAP1 KIAA1671 TNRC18 MAP7D1 SYNJ1 NFATC1 ZNF592 TLE1 BRD4 SYNE2 MKI67 HEY2 NAV1 KMT2A PLEKHA5 AKAP1 RAI1	7.49e-05	1108	184	24	int:HDAC1
Interaction	RAB35 interactions	CDCA3 MYO5A WDR7 TEX2 DTNA SPTBN1 APBB2 NIBAN2 SBF1 BASP1 SYNE2 PLEKHA5 MARK2 PARD3 AKAP1 EIF2AK3	7.63e-05	573	184	16	int:RAB35
Interaction	TNK2 interactions	DENND2A ANK2 MAP4 SPTBN1 GTSE1 SRCIN1 BCAR1 HSH2D CTNND2	7.88e-05	195	184	9	int:TNK2
Interaction	TBR1 interactions	ZNF609 BRD3 BAP1 NFIB TLE1 BRD4 TBR1	8.07e-05	113	184	7	int:TBR1
Interaction	ZNF281 interactions	BRD3 BCAR1 TERF2 EGR2 NFIB CDC16 BRD4 BRD1 SLX4	8.52e-05	197	184	9	int:ZNF281
Interaction	H2BC3 interactions	TCF20 SPTBN1 GON4L BRD3 TERF2 PIAS1 BAP1 LIG3 BASP1 BRD4 MDC1 KMT2A RAI1	9.57e-05	406	184	13	int:H2BC3
Interaction	ASF1A interactions	TCF20 INCENP BCORL1 NSD1 BLM ZNF592 MDC1 MSL3 KMT2A RAI1	1.01e-04	249	184	10	int:ASF1A
Interaction	MYCBP2 interactions	ANK2 PRR36 MAP4 SPTBN1 CCDC177 BAP1 PRRC2C SYNE2 ROBO2 PKN1 LSM14A TBR1	1.08e-04	355	184	12	int:MYCBP2
Interaction	NUMA1 interactions	NUP88 BRD3 PRC1 TERF2 LIG3 CDC16 BRD4 ARHGAP44 MDC1 MKI67 KMT2A BRD1 SLX4 RAI1	1.08e-04	469	184	14	int:NUMA1
Interaction	MDC1 interactions	TCF20 NSD1 BRD3 PRC1 TERF2 PIAS1 LIG3 CDC16 BRD4 MDC1 MKI67 BOD1L1 SLX4	1.16e-04	414	184	13	int:MDC1
Interaction	STX7 interactions	CDCA3 NIBAN1 MYO5A WDR7 TEX2 DTNA SPTBN1 APBB2 NIBAN2 BAP1 SYNJ1 BASP1 SYNE2 PLEKHA5 MARK2 PARD3 EIF2AK3	1.19e-04	659	184	17	int:STX7
Interaction	HINFP interactions	POM121C PRRC2C MDC1 MKI67 SRRM2	1.21e-04	53	184	5	int:HINFP
Interaction	SYNGAP1 interactions	EVL CACNB2 ANK2 MYO5A MAP4 WDR7 SPTBN1 SYNJ1 BASP1 SYNE2 IQSEC1	1.26e-04	307	184	11	int:SYNGAP1
Interaction	HMGA1 interactions	TCF20 NSD1 PRC1 FOXA1 TERF2 PIAS1 LIG3 TNRC18 NFATC1 BRD4 MDC1 KMT2A RAI1	1.31e-04	419	184	13	int:HMGA1
Interaction	EEF1AKMT3 interactions	MEX3D ARHGEF12 NIBAN2 WNK1 KIAA1671 RIN1 SBF1 OSBPL3 IQSEC1 NAV1 PATJ LRRC41	1.36e-04	364	184	12	int:EEF1AKMT3
Interaction	FBXO22 interactions	SPEG SPTBN1 BRD3 SRCIN1 BCAR1 BLM MAP7D1 PTPRB MAP1S ZNF592 NAV2 KMT2A PLEKHA5 MARK2 RAI1	1.36e-04	540	184	15	int:FBXO22
Interaction	NFIC interactions	ZNF609 FOXA1 EGR2 NFIB TLE1 BRD4 MDC1 MKI67 TBR1	1.38e-04	210	184	9	int:NFIC
GeneFamily	Fibronectin type III domain containing	MYBPH ABI3BP ANOS1 PTPRB CNTN5 ROBO2 IGSF9B	6.20e-05	160	112	7	555
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE1 SYNE2	2.26e-04	4	112	2	1252
GeneFamily	CD molecules\|Mucins	MUC16 MUC12 MUC20	2.84e-04	21	112	3	648
GeneFamily	PDZ domain containing	ARHGEF12 MAST4 SNTG2 RIMS1 PATJ PARD3	3.68e-04	152	112	6	1220
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND2A SBF1 DENND4B	4.82e-04	25	112	3	504
GeneFamily	N-BAR domain containing	ARHGAP44 BIN2	2.41e-03	12	112	2	1289
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYBPH SPEG CNTN5 ROBO2 IGSF9B	3.28e-03	161	112	5	593
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ANK2 ADAMTS3 MYO5A SPEG APC2 ARHGEF12 TATDN2 ADGRL1 SRCIN1 TTC3 CHRNA4 ZFPM2 MAST4 CELSR3 SYNJ1 SNAP91 BASP1 VCAN CNTN5 NAV3 NAV1 ROBO2 BOD1L1 IGSF9B RIMS1 CTNND2 KLHL14 BRD1 RAI1	1.07e-09	1106	185	29	M39071
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	ANK2 MYO5A MUC16 SRCIN1 FOXA1 TERF2 CHRNA4 CELSR3 SYNJ1 SNAP91 BASP1 NAV3 ROBO2 RIMS1 KLHL14 NYAP1 AKAP1	1.28e-07	506	185	17	M39067
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	ANK2 MAST4 NFIB PRRC2C SYNE2 PLEKHA5 WDFY3 PATJ PARD3 SRRM2 TNS1	5.32e-07	221	185	11	M39222
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	HIVEP2 WDR7 TEX2 DTNA SPTBN1 APBB2 NSD1 GON4L PIAS1 KIAA1671 LIG3 PTPRB KIAA1217 SYNE2 LSM14A PATJ SRRM2 AKAP1 TNS1 MGRN1	1.23e-06	807	185	20	M16651
Coexpression	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN	TATDN2 PRC1 TTC3 S1PR3 ZFP36 HSH2D LSM14A BIN2 RASGRP2	1.13e-05	196	185	9	M6126
Coexpression	GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN	BCORL1 ADGRL1 LIG3 OSBPL3 SYNE2 CNGB3 KMT2A HSH2D RAI1	1.27e-05	199	185	9	M7498
Coexpression	GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	XIRP1 HIVEP2 SPEG APC2 CFAP54 PLCH2 CNGB3 NAV3 RASGRP2	1.27e-05	199	185	9	M6631
Coexpression	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	TCF20 SYNE1 TTC3 TCP11L2 IQSEC1 PATJ PRG4 MGRN1	1.31e-05	152	185	8	M2938
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN	EVL TCF20 SYNE1 BCORL1 ADGRL1 TTC3 PATJ MGRN1	2.07e-05	162	185	8	M7002
Coexpression	JIANG_TIP30_TARGETS_DN	PCGF2 IGF2 SRRM2 AKAP1	2.29e-05	24	185	4	M13930
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	ANK2 SPEG APC2 SRCIN1 ZFPM2 CELSR3 BASP1 NAV1 ROBO2 RIMS1 KLHL14 AKAP1 EFCAB7	2.86e-05	465	185	13	M39066
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	MAST4 NFIB KIAA1217 SYNE2 PLEKHA5 WDFY3 PATJ PARD3	3.75e-05	176	185	8	M39223
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	LARP1 GON4L CCND3 KIAA1671 PRRC2C BRD4 ROBO2 PLEKHA5 PLCG2 MARK2 SRRM2 TNS1	4.41e-05	417	185	12	M39224
Coexpression	HEVNER_CORTEX_ROSTRAL_INTERMEDIATE_ZONE	TUB NAV2 TBR1	5.48e-05	11	185	3	MM447
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	SYNE1 SPTBN1 APBB2 ARHGEF12 PIAS1 PTPRB KIAA1217	5.53e-05	137	185	7	M39241
Coexpression	GSE13411_NAIVE_VS_MEMORY_BCELL_UP	ZFPM2 LIG3 SYNJ1 SNAP91 ARHGAP44 NAV3 SNTG2 RIMS1	6.93e-05	192	185	8	M3245
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	CDCA3 POLH BRD3 PRC1 CCND3 SYNE2 KMT2A PSRC1	7.45e-05	194	185	8	M7467
Coexpression	GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP	GARIN5B GTSE1 CCND3 RIMBP3 NKX6-3 PLCH2 SERPINA9	7.92e-05	145	185	7	M6758
Coexpression	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN	BRD3 TTC3 ZC3H7A PLCH2 MDC1 PATJ AKAP1 RAI1	8.30e-05	197	185	8	M7921
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	NIBAN1 MYO5A SYNE1 PRC1 WNK1 TNRC18 ARHGAP31 PLEKHA5	8.59e-05	198	185	8	M6511
Coexpression	GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN	CDCA3 EVL TCF20 SPEG SRCIN1 PRC1 EGR2 UTF1	8.90e-05	199	185	8	M8542
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	TCF20 NACA BRD3 PIAS1 MSL3 KMT2A ASXL2 BRD1	8.90e-05	199	185	8	M7596
Coexpression	GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP	S1PR3 TCP11L2 UBAP2L KIAA1217 MKI67 DEPDC5 AKAP1 PSRC1	9.22e-05	200	185	8	M5985
Coexpression	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	PRR36 POLH LIG3 IGSF9B MARK2 CTNND2 TRAPPC14 PATJ	9.22e-05	200	185	8	M8975
Coexpression	GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP	MYO5A APBB2 TTC3 WNK1 BRD4 MKI67 NAV2 LSM14A	9.22e-05	200	185	8	M9083
Coexpression	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN	MYBPH NIBAN1 HIVEP2 NSD1 AGPS TERF2 BASP1 KLHL14	9.22e-05	200	185	8	M5715
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	EVL PRR36 NACA FOXA1 TTC3 PRRC2C DENND4B IQSEC1 CTNND2 SRRM2 MGRN1	9.81e-05	385	185	11	M2840
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	HIVEP2 GGN SYNE1 AMIGO3 SYNJ1 PRRC2C ASXL2	1.30e-04	157	185	7	M7733
Coexpression	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	MEX3D BRD3 TTC3 IGF2 PRRC2C CTNND2	1.78e-04	116	185	6	M14146
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	WNK1 ZC3H7A NAV2 NAV1 BOD1L1 DEPDC5 ASXL2	1.84e-04	166	185	7	M6826
Coexpression	LIAO_HAVE_SOX4_BINDING_SITES	MAP4 UBAP2L VCAN NAV3	1.98e-04	41	185	4	M15025
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL	CDCA3 NIBAN1 ANK2 INCENP MEX3D GTSE1 BLM MAP7D1 VCAN MDC1 MKI67 CTNND2 PSRC1	2.08e-04	567	185	13	M45692
Coexpression	THUM_SYSTOLIC_HEART_FAILURE_DN	NIBAN1 SYNE1 SPTBN1 TTC3 MAST4 KIAA1217 HEY2 PLEKHA5	2.20e-04	227	185	8	M18441
Coexpression	GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP	NIBAN1 INCENP GTSE1 PRC1 EGR2 MKI67 SERPINA9	2.29e-04	172	185	7	M8932
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNPROG	CDCA3 GTSE1 VXN PRC1 ANOS1 CELSR3 MKI67 PSRC1	2.33e-04	229	185	8	M39062
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	MAP4 TNRC18 MAST4 NFIB PRRC2C KIAA1217 SYNE2 NAV2 DEPDC5 WDFY3	8.06e-07	150	185	10	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	MAP4 SPTBN1 BCORL1 TNRC18 MAST4 ARHGAP31 NFIB PRRC2C KIAA1217 SYNE2 NAV2 DEPDC5 WDFY3	1.18e-06	281	185	13	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	MAP4 SPTBN1 BCORL1 TNRC18 MAST4 PRRC2C KIAA1217 NAV2 DEPDC5 WDFY3	1.63e-06	162	185	10	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	EVL CACNB2 TCF20 MAP4 NUP88 ARHGEF12 GON4L ZC3H7A MAP7D1 MAST4 BASP1 SYNE2 MKI67 ROBO2 PLEKHA5 PRR14L TRAPPC14 MAP3K7 ANKRD40 EIF2AK3 SLX4	4.75e-06	780	185	21	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000	MAP4 TNRC18 MAST4 ARHGAP31 NFIB PRRC2C KIAA1217 SYNE2 NAV2 ROBO2 DEPDC5 WDFY3	7.77e-06	284	185	12	gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	MAP4 SPTBN1 BCORL1 TNRC18 MAST4 NFIB PRRC2C SYNE2 NAV2 DEPDC5 WDFY3	1.24e-05	249	185	11	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	MAP4 SPTBN1 BCORL1 TNRC18 MAST4 NFIB PRRC2C KIAA1217 SYNE2 NAV2 ROBO2 DEPDC5 WDFY3 TNS1	1.38e-05	406	185	14	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	MAP4 SPTBN1 TNRC18 MAST4 NFIB PRRC2C KIAA1217 SYNE2 NAV2 DEPDC5 WDFY3	1.79e-05	259	185	11	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500	NIBAN1 ABI3BP ADAMTS3 MAGEE1 FOXA1 PIAS1 S1PR3 ZFPM2 ZNF469 IGF2 NFIB VCAN SNTG2 MAP3K7	2.11e-05	422	185	14	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500	MAP4 SPTBN1 BCORL1 TNRC18 NFIB PRRC2C KIAA1217 SYNE2 WDFY3	2.37e-05	175	185	9	gudmap_developingGonad_e14.5_ epididymis_500_k4
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500	MAP4 SPTBN1 BCORL1 MAST4 NFIB PRRC2C SYNE2 WDFY3	2.60e-05	136	185	8	gudmap_developingGonad_P2_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	MAP4 SPTBN1 BCORL1 MAST4 NFIB PRRC2C SYNE2 NAV2 DEPDC5 WDFY3	3.54e-05	230	185	10	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	CDCA3 DENND2A CACNB2 ZNF609 PCGF2 ANK2 MYO5A PRR36 DTNA NSD1 PRC1 TTC3 CFAP54 ZBED4 SYNJ1 SNAP91 BRD4 ARHGAP44 SYNE2 MKI67 BOD1L1 RIMS1 WDFY3 KLHL14 BRD1 EFCAB7 PSRC1	5.82e-05	1370	185	27	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	MAP4 SPTBN1 BCORL1 TNRC18 MAST4 NFIB PRRC2C KIAA1217 SYNE2 ROBO2 DEPDC5 WDFY3 TNS1	7.15e-05	413	185	13	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200	NIBAN1 NSD1 FOXA1 IGF2 NFIB VCAN ASXL2 MAP3K7	1.31e-04	171	185	8	gudmap_developingLowerUrinaryTract_e14.5_ bladder_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	CACNB2 NIBAN1 ADAMTS3 POLH MUC16 ADGRL1 PRC1 S1PR3 ZFPM2 SNCAIP EGR2 NFIB KIAA1217 VCAN SYNE2 NAV1 ROBO2 RASGRP2	1.50e-04	773	185	18	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	MAP4 SPTBN1 MAST4 NFIB PRRC2C KIAA1217 SYNE2 NAV2 DEPDC5 WDFY3	1.66e-04	277	185	10	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	MAP4 DTNA TNRC18 MAST4 NFIB PRRC2C KIAA1217 SYNE2 NAV2 ROBO2 DEPDC5 WDFY3	2.27e-04	403	185	12	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	MAP4 DTNA SPTBN1 TERF2 TNRC18 MAST4 SBNO1 UBAP2L NFIB PRRC2C KIAA1217 SYNE2 NAV2 ROBO2 DEPDC5 WDFY3 TNS1 UTF1	2.51e-04	806	185	18	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	NIBAN1 ABI3BP ADAMTS3 POLH MAGEE1 FOXA1 PIAS1 S1PR3 ZFPM2 ZC3H7A ZNF469 IGF2 PTPRB NFIB PRRC2C VCAN SNTG2 MAP3K7	3.36e-04	826	185	18	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500	NIBAN1 NSD1 FOXA1 S1PR3 ZFPM2 ZNF469 IGF2 NFIB VCAN SNTG2 ASXL2 MAP3K7	3.37e-04	421	185	12	gudmap_developingLowerUrinaryTract_e14.5_ bladder_500
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000	HIVEP2 SPTBN1 APBB2 NIBAN2 ZFP36 CRIP2 NHSL1 ZC3H7A IGF2 PTPRB EGR2 ARHGAP31 NFIB SYCP1 NAV3 NAV1 PLCG2 RASGRP2	3.61e-04	831	185	18	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500	MAP4 SPTBN1 BCORL1 NFIB PRRC2C SYNE2 WDFY3	3.80e-04	152	185	7	gudmap_developingGonad_e18.5_epididymis_500_k4
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	MUC16 S1PR3 ZFPM2 EGR2 KIAA1217 VCAN ROBO2	3.96e-04	153	185	7	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	CACNB2 ABI3BP MYO5A SPTBN1 WNK1 MAST4 SYNJ1 SNAP91 UBAP2L PRRC2C SYNE2 SYCP1 NAV2 RIMS1 PLCG2 WDFY3 PARD3	4.26e-04	770	185	17	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	SYNE1 SPEG AGPS FOXA1 S1PR3 ZFPM2 IGF2 NKD1 NFIB PRRC2C VCAN PLEKHA5 SNTG2 ASXL2 RIMS1 AKAP1 MGRN1	4.38e-04	772	185	17	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	CACNB2 ABI3BP MUC16 S1PR3 ZFPM2 SNCAIP NKD1 EGR2 NFIB KIAA1217 VCAN MDC1 MKI67 HEY2 NAV1 ROBO2 TNS1	4.72e-04	777	185	17	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	GON4L LIG3 IGF2 SBNO1 PRRC2C VCAN PLEKHA5 ASXL2 MGRN1	4.90e-04	261	185	9	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	DENND2A CACNB2 ABI3BP DTNA APBB2 NKD1 NFIB NAV3 NAV2 ROBO2 PLEKHA5 PARD3	3.79e-11	195	185	12	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APBB2 ARHGEF12 ZFPM2 KIAA1671 PTPRB MAST4 ARHGAP31 NFIB KIAA1217 ROBO2 CTNND2	6.03e-10	194	185	11	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	SYNE1 SPTBN1 ARHGEF12 CFAP54 MAST4 NFIB KIAA1217 SYNE2 NAV2 PLEKHA5 PARD3	6.37e-10	195	185	11	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	SYNE1 SPTBN1 ARHGEF12 CFAP54 MAST4 NFIB KIAA1217 SYNE2 NAV2 PLEKHA5 PARD3	6.37e-10	195	185	11	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	SYNE1 SPTBN1 ARHGEF12 CFAP54 MAST4 NFIB KIAA1217 SYNE2 MKI67 NAV2 PARD3	6.73e-10	196	185	11	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	SYNE1 SPTBN1 ARHGEF12 CFAP54 MAST4 NFIB KIAA1217 SYNE2 MKI67 NAV2 PARD3	6.73e-10	196	185	11	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DENND2A SYNE1 SPTBN1 APBB2 ZFPM2 MAST4 TLE1 SYNE2 IQSEC1 PARD3 TNS1	8.33e-10	200	185	11	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DENND2A SYNE1 SPTBN1 APBB2 ZFPM2 MAST4 TLE1 SYNE2 IQSEC1 PARD3 TNS1	8.33e-10	200	185	11	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DENND2A SYNE1 SPTBN1 APBB2 ZFPM2 MAST4 TLE1 SYNE2 IQSEC1 PARD3 TNS1	8.33e-10	200	185	11	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DENND2A SYNE1 SPTBN1 APBB2 ZFPM2 MAST4 TLE1 SYNE2 IQSEC1 PARD3 TNS1	8.33e-10	200	185	11	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DENND2A SYNE1 SPTBN1 APBB2 ZFPM2 MAST4 TLE1 SYNE2 IQSEC1 PARD3 TNS1	8.33e-10	200	185	11	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DENND2A SYNE1 SPTBN1 APBB2 ZFPM2 MAST4 TLE1 SYNE2 IQSEC1 PARD3 TNS1	8.33e-10	200	185	11	7136936d05ab344a560cf159684c881063b5430d
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	DENND2A CACNB2 ANK2 ABI3BP ADAMTS3 PI16 ZFPM2 VCAN NAV3 ROBO2	6.85e-09	188	185	10	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A CACNB2 ANK2 ABI3BP DTNA ZFPM2 NKD1 NAV3 NAV2 ROBO2	7.97e-09	191	185	10	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A CACNB2 ANK2 ABI3BP DTNA ZFPM2 NKD1 NAV3 NAV2 ROBO2	8.38e-09	192	185	10	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	SYNE1 SPTBN1 ARHGEF12 MAST4 NFIB KIAA1217 SYNE2 NAV2 PATJ PARD3	9.72e-09	195	185	10	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	SYNE1 SPTBN1 ARHGEF12 MAST4 NFIB KIAA1217 SYNE2 NAV2 PATJ PARD3	9.72e-09	195	185	10	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	CACNB2 ABI3BP DTNA APBB2 ZFPM2 NFIB VCAN NAV3 ROBO2 PARD3	1.07e-08	197	185	10	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDCA3 INCENP PRC1 S1PR3 SNCAIP NFIB VCAN MKI67 ROBO2 PSRC1	1.12e-08	198	185	10	148f5fee19ea8dff7f2de4ca69c3b03e5221985d
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A ANK2 ABI3BP PI16 SYNE1 ZFPM2 VCAN NAV3 NAV2 NAV1	1.24e-08	200	185	10	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A ANK2 ABI3BP PI16 SYNE1 ZFPM2 VCAN NAV3 NAV2 NAV1	1.24e-08	200	185	10	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A CACNB2 ANK2 ABI3BP ZFPM2 NKD1 VCAN NAV3 NAV2 ROBO2	1.24e-08	200	185	10	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A CACNB2 ANK2 ABI3BP ADAMTS3 PI16 ZFPM2 VCAN NAV3 NAV1	1.24e-08	200	185	10	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	ABI3BP ADAMTS3 DTNA SYNE1 ZFPM2 CFAP54 VCAN ROBO2 TNS1	4.56e-08	172	185	9	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	CACNB2 DTNA SPEG S1PR3 ZFPM2 NKD1 VCAN IGSF9B TNS1	6.74e-08	180	185	9	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPTBN1 APBB2 ANOS1 ARHGAP44 NAV2 CTNND2 PATJ PARD3 TNS1	8.14e-08	184	185	9	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPTBN1 APBB2 ANOS1 ARHGAP44 NAV2 CTNND2 PATJ PARD3 TNS1	8.14e-08	184	185	9	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A CACNB2 ABI3BP DTNA ZFPM2 SNCAIP NKD1 ROBO2 RIMS1	8.52e-08	185	185	9	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	ILEUM-inflamed-(7)_Lymphatics\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPTBN1 CHRNA4 CRIP2 KIAA1671 IGF2 SNCAIP NFIB KIAA1217 TNS1	8.52e-08	185	185	9	d711dd2e91cfee723dae1ccb2b910b8cf3becc3b
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	TTC3 TUB CHRNA4 CNNM1 CELSR3 SYNJ1 ARHGAP44 RIMS1 NYAP1	8.93e-08	186	185	9	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DENND2A CACNB2 ABI3BP DTNA ZFPM2 NKD1 NAV3 NAV2 ROBO2	9.34e-08	187	185	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	APBB2 KIAA1671 CFAP54 SNCAIP PTPRB MAST4 ARHGAP31 SYNE2 SNTG2	9.34e-08	187	185	9	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DENND2A BCAR1 ZFPM2 KIAA1671 SNCAIP PTPRB TLE1 SNTG2 KLHL14	9.78e-08	188	185	9	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DENND2A BCAR1 ZFPM2 KIAA1671 SNCAIP PTPRB TLE1 SNTG2 KLHL14	9.78e-08	188	185	9	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A CACNB2 ABI3BP DTNA SYNE1 SPEG ZFPM2 SNTG2 RIMS1	1.02e-07	189	185	9	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	DENND2A CACNB2 ANK2 ABI3BP ZFPM2 NKD1 VCAN NAV3 ROBO2	1.07e-07	190	185	9	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	CACNB2 NIBAN1 ANK2 DTNA ZFPM2 MAST4 PLEKHA5 CTNND2 PATJ	1.12e-07	191	185	9	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SYNE1 SPTBN1 ARHGEF12 MAST4 NFIB KIAA1217 SYNE2 PATJ PARD3	1.17e-07	192	185	9	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	POLH GTSE1 LARP1 PRRC2C BRD4 MKI67 KMT2A BOD1L1 SRRM2	1.17e-07	192	185	9	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	DENND2A CACNB2 ABI3BP APBB2 ZFPM2 NAV3 ROBO2 PLEKHA5 PARD3	1.22e-07	193	185	9	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APBB2 ZFPM2 KIAA1671 PTPRB MAST4 ARHGAP31 KIAA1217 NAV1 CTNND2	1.28e-07	194	185	9	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EVL DENND2A CACNB2 ANK2 ABI3BP ADAMTS3 DTNA SYNE1 NKD1	1.28e-07	194	185	9	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APBB2 ZFPM2 KIAA1671 PTPRB MAST4 ARHGAP31 KIAA1217 NAV1 CTNND2	1.28e-07	194	185	9	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CACNB2 ANK2 ABI3BP SNCAIP BASP1 NFIB ROBO2 SNTG2 RIMS1	1.34e-07	195	185	9	1daddd801bd4596fffbdb822fc326d5127c96004
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD1 TTC3 SYNJ1 PRRC2C NAV2 KMT2A ROBO2 BOD1L1 SRRM2	1.34e-07	195	185	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A CACNB2 ANK2 ABI3BP ZFPM2 NKD1 NAV3 NAV2 ROBO2	1.39e-07	196	185	9	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-tip_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PCGF2 BCAR1 CRIP2 KIAA1671 PTPRB MAST4 ARHGAP31 NFIB KIAA1217	1.46e-07	197	185	9	b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDCA3 INCENP PRC1 SNCAIP NFIB VCAN MKI67 ROBO2 PSRC1	1.46e-07	197	185	9	29b0a5927f80455eef7b793feabef69fba1a3df1
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	DENND2A CACNB2 ANK2 ABI3BP DTNA VCAN NAV3 NAV2 ROBO2	1.52e-07	198	185	9	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A CACNB2 ANK2 ABI3BP ZFPM2 NKD1 NAV3 NAV2 ROBO2	1.52e-07	198	185	9	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A CACNB2 ANK2 ABI3BP PI16 ZFPM2 VCAN NAV3 NAV1	1.66e-07	200	185	9	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A CACNB2 ANK2 ABI3BP ZFPM2 NKD1 VCAN NAV3 ROBO2	1.66e-07	200	185	9	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP4 SPTBN1 ARHGEF12 CRIP2 IGF2 PTPRB NFIB KIAA1217 SYNE2	1.66e-07	200	185	9	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A CACNB2 ANK2 ABI3BP ZFPM2 NKD1 VCAN NAV3 ROBO2	1.66e-07	200	185	9	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A ANK2 ABI3BP SYNE1 ZFPM2 VCAN NAV3 NAV2 TNS1	1.66e-07	200	185	9	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SPTBN1 ARHGEF12 CRIP2 IGF2 PTPRB MAST4 NFIB KIAA1217 SYNE2	1.66e-07	200	185	9	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP4 SPTBN1 ARHGEF12 CRIP2 IGF2 PTPRB NFIB KIAA1217 SYNE2	1.66e-07	200	185	9	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPTBN1 ARHGEF12 IGF2 PTPRB MAST4 NFIB KIAA1217 SYNE2 KMT2A	1.66e-07	200	185	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	SPTBN1 ARHGEF12 CRIP2 IGF2 PTPRB MAST4 NFIB TLE1 KIAA1217	1.66e-07	200	185	9	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SPTBN1 ARHGEF12 CRIP2 IGF2 PTPRB MAST4 NFIB KIAA1217 SYNE2	1.66e-07	200	185	9	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A ABI3BP PI16 SYNE1 ZFPM2 VCAN NAV3 NAV2 ROBO2	1.66e-07	200	185	9	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A CACNB2 ANK2 ABI3BP ZFPM2 NKD1 VCAN NAV3 ROBO2	1.66e-07	200	185	9	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	EVL CACNB2 ANK2 ABI3BP ADAMTS3 SYNE1 S1PR3 VCAN TNS1	1.66e-07	200	185	9	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Dividing_Macrophages-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	CDCA3 SRRM5 XIRP1 INCENP GTSE1 PRC1 MKI67 PSRC1	2.02e-07	148	185	8	66b51aa6690bf8fbc90fa5a6f86191703e2d5046
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NIBAN1 FOXA1 MAST4 KIAA1217 NAV2 RIMS1 PATJ AKAP1	4.04e-07	162	185	8	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	SPTBN1 APBB2 ARHGEF12 ARHGAP44 NAV2 PATJ PARD3 TNS1	5.83e-07	170	185	8	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	DENND2A ZFPM2 KIAA1671 SNCAIP PTPRB TLE1 SNTG2 NYAP1	6.65e-07	173	185	8	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	CDCA3 GTSE1 NIBAN2 PRC1 VCAN MKI67 WDFY3 PSRC1	6.65e-07	173	185	8	783b8fa08b9d8f597f251793eae164151662f1f9
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDCA3 INCENP POLH PRC1 PTPRB ZBED4 CASTOR1 PSRC1	6.95e-07	174	185	8	6c36d607c48267a75ab4da6fb2fe3f931d1b3b52
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	SPTBN1 APBB2 ANOS1 ARHGAP44 NAV2 CTNND2 PATJ TNS1	6.95e-07	174	185	8	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNB2 ANK2 WDR7 DTNA SYNE1 SYNJ1 ROBO2 MAP3K7	7.26e-07	175	185	8	1d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNB2 ANK2 WDR7 DTNA SYNE1 SYNJ1 ROBO2 MAP3K7	7.26e-07	175	185	8	427a7ee92fe16a90625946492062d37aa0f7235b
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	DENND2A ZFPM2 KIAA1671 NHSL1 SNCAIP PTPRB SNTG2 NYAP1	7.58e-07	176	185	8	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	DENND2A ZFPM2 KIAA1671 NHSL1 SNCAIP PTPRB SNTG2 NYAP1	7.58e-07	176	185	8	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NIBAN1 CD46 FOXA1 MAST4 KIAA1217 NAV2 RIMS1 PATJ	7.58e-07	176	185	8	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	APBB2 SNCAIP PTPRB MAST4 ARHGAP31 KIAA1217 SYNE2 SNTG2	8.61e-07	179	185	8	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABI3BP SPTBN1 CHRNA4 ZFPM2 SNCAIP NAV3 KLHL14 NYAP1	1.02e-06	183	185	8	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	CACNB2 XIRP1 ANK2 MAP4 DTNA MAST4 PLEKHA5 CTNND2	1.06e-06	184	185	8	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNB2 ANK2 ABI3BP ZFPM2 NFIB NAV3 NAV2 PARD3	1.10e-06	185	185	8	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	CDCA3 INCENP GTSE1 PRC1 BLM MKI67 KLHL14 SERPINA9	1.10e-06	185	185	8	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 ABI3BP DTNA SYNE1 SPEG ZFPM2 ROBO2 RIMS1	1.10e-06	185	185	8	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 NSD1 IGF2 SNCAIP PTPRB ARHGAP31 PRRC2C SYNE2	1.15e-06	186	185	8	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DENND2A SPTBN1 BCAR1 ZFPM2 SNCAIP NAV3 PLCG2 KLHL14	1.15e-06	186	185	8	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNB2 DTNA S1PR3 ZFP36 NKD1 NAV3 NAV2 ROBO2	1.20e-06	187	185	8	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	droplet-Fat-SCAT-30m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 SPTBN1 APBB2 CRIP2 KIAA1671 PTPRB ARHGAP31 TNS1	1.24e-06	188	185	8	5cf060bb8adaefa9964187195d67993c1248ef47
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PRR36 TTC3 CHRNA4 CNNM1 CELSR3 SYNJ1 RIMS1 NYAP1	1.24e-06	188	185	8	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	droplet-Fat-SCAT-30m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 SPTBN1 APBB2 CRIP2 KIAA1671 IGF2 PTPRB TNS1	1.24e-06	188	185	8	e901a9bdf00b8e91806f445af66647373bf62661
ToppCell	droplet-Fat-SCAT-30m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 SPTBN1 APBB2 CRIP2 KIAA1671 PTPRB ARHGAP31 TNS1	1.24e-06	188	185	8	449f9602df3c83b2110eb479a00d428d1b55b423
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BCAR1 ZFPM2 KIAA1671 SNCAIP PTPRB TLE1 SNTG2 KLHL14	1.24e-06	188	185	8	2db80767903703e7e0a1a37c598f7877a909ee94
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	CACNB2 ABI3BP ADAMTS3 MUC16 ZFPM2 MAST4 PARD3 PRG4	1.29e-06	189	185	8	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYNE1 SPTBN1 PTPRB ARHGAP31 NFIB KIAA1217 SYNE2 SNTG2	1.29e-06	189	185	8	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDCA3 INCENP GTSE1 PRC1 SYCP1 MKI67 NAV2 PSRC1	1.29e-06	189	185	8	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CACNB2 NIBAN1 XIRP1 ANK2 ARHGEF12 MAST4 KIAA1217 EIF2AK3	1.29e-06	189	185	8	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 NIBAN1 ABI3BP DTNA SPEG ZFPM2 NKD1 ROBO2	1.29e-06	189	185	8	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	ANK2 ABI3BP ADAMTS3 PI16 ZFPM2 NFIB NAV3 NAV1	1.35e-06	190	185	8	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A ANK2 ABI3BP DTNA MAST4 OSBPL3 SNTG2 PATJ	1.35e-06	190	185	8	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPTBN1 APBB2 ARHGAP44 NAV2 CTNND2 PATJ PARD3 TNS1	1.35e-06	190	185	8	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NIBAN1 MAP4 SPTBN1 ARHGEF12 PTPRB NFIB NAV1 ROBO2	1.35e-06	190	185	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EVL DENND2A CACNB2 ANK2 ABI3BP ADAMTS3 DTNA VCAN	1.40e-06	191	185	8	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DTNA KIAA1671 MAST4 NFIB SYNE2 PLEKHA5 PATJ PARD3	1.40e-06	191	185	8	1c1d13144259b998d4a0e85142f7afef2ef1e63f
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ZNF609 MAP4 WDR7 APBB2 LIG3 MAST4 NFIB TLE1 LSM14A CTNND2 PARD3 PSRC1	2.94e-08	183	182	12	5613_DN
Drug	Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ZNF609 PCGF2 DTNA WNK1 LIG3 SYNJ1 TLE1 BRD4 CNGB3 HEY2 PATJ LRRC41	7.02e-08	198	182	12	1689_UP
Drug	resveratrol; Down 200; 50uM; MCF7; HG-U133A	CDCA3 ZNF609 SPTBN1 GTSE1 NUP88 PRC1 MAP1S UBAP2L MKI67 IQSEC1 PSRC1	3.56e-07	188	182	11	595_DN
Drug	Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A	ZNF609 SPEG LIG3 MAP7D1 ZNF592 BRD4 PACS2 PKN1 CTNND2 PATJ PARD3	4.87e-07	194	182	11	4838_UP
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	DENND2A MAP4 SYNE1 SPTBN1 ZNF592 BRD4 DENND4B VCAN NAV3 BRD1 TRAPPC14	5.40e-07	196	182	11	6619_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A	HIVEP2 MAP4 ARHGEF12 GON4L WNK1 NFATC1 RIMS1 MARK2 TRAPPC14 TNS1 RASGRP2	6.60e-07	200	182	11	1164_UP
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	ZNF609 HIVEP2 WDR7 APBB2 PIAS1 MAST4 NFIB PLEKHA5 WDFY3 PARD3	1.45e-06	174	182	10	7530_DN
Drug	Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; MCF7; HT_HG-U133A	CDCA3 GTSE1 APBB2 PRC1 NFIB MKI67 TRAPPC14 SRRM2 PSRC1 LRRC41	2.17e-06	182	182	10	3317_DN
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A	INCENP PRR36 MAP4 DTNA GTSE1 GON4L WNK1 ZBED4 KMT2A SRRM2	2.28e-06	183	182	10	1709_DN
Drug	lomustine; Down 200; 100uM; PC3; HT_HG-U133A	CDCA3 DENND2A PCGF2 HIVEP2 CRIP2 LIG3 LSM14A WDFY3 AKAP1 PSRC1	2.90e-06	188	182	10	7050_DN
Drug	resveratrol; Down 200; 50uM; MCF7; HG-U133A	SPTBN1 GTSE1 ADGRL1 PRC1 MAP7D1 CDC16 DENND4B MKI67 SRRM2 PSRC1	3.19e-06	190	182	10	622_DN
Drug	Methotrexate [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A	HIVEP2 ADGRL1 WNK1 ZFP36 ZBED4 BRD4 MKI67 PARD3 TNS1 PSRC1	3.19e-06	190	182	10	6318_DN
Drug	Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A	ZNF609 ADGRL1 WNK1 RIN1 LIG3 NAV2 DEPDC5 LSM14A TBR1 SRRM2	3.51e-06	192	182	10	4129_UP
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A	PCGF2 GTSE1 GON4L ADGRL1 LIG3 MAP7D1 MAP1S ZBED4 CTNND2 ANKRD40	3.85e-06	194	182	10	1642_DN
Drug	Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; PC3; HT_HG-U133A	PCGF2 SPEG SPTBN1 GTSE1 GON4L RIN1 SBF1 UBAP2L BRD4 LRRC41	4.21e-06	196	182	10	2110_DN
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; PC3; HT_HG-U133A	PCGF2 INCENP GON4L ADGRL1 CNNM1 MAST4 SYNJ1 CNGB3 PLCG2 TNS1	4.21e-06	196	182	10	7371_UP
Drug	Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A	ZNF609 MAP4 CHRNA4 MAST4 ZBED4 NAV2 LSM14A MARK2 PARD3 LRRC41	4.21e-06	196	182	10	5338_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A	MAP4 BCORL1 ARHGEF12 WNK1 MAST4 SBF1 TLE1 CNGB3 LSM14A SRRM2	4.41e-06	197	182	10	3277_DN
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; PC3; HT_HG-U133A	HIVEP2 MAP4 ZFP36 IGF2 SBF1 NFATC1 NFIB MSL3 WDFY3 PARD3	4.61e-06	198	182	10	6304_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; HL60; HT_HG-U133A	MAP4 BAP1 SBF1 BRD4 VCAN ARHGAP44 MSL3 WDFY3 TRAPPC14 TNS1	4.61e-06	198	182	10	2555_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	PCGF2 MAP4 CELSR3 CNGB3 IQSEC1 PACS2 PLCG2 MARK2 PATJ AKAP1	4.61e-06	198	182	10	5325_DN
Drug	Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A	SPTBN1 APBB2 CNNM1 LIG3 SNCAIP PTPRB MSL3 CTNND2 TRAPPC14 RASGRP2	4.61e-06	198	182	10	4280_UP
Drug	Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; PC3; HG-U133A	ZNF609 ADAMTS3 MAP4 DTNA ARHGEF12 PIAS1 PRRC2C BRD4 NAV2 PARD3	4.61e-06	198	182	10	1962_UP
Drug	Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	INCENP SPTBN1 WNK1 CNNM1 LIG3 TLE1 PLCH2 CNTN5 WDFY3 RASGRP2	4.82e-06	199	182	10	7234_UP
Drug	Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A	ZNF609 DTNA WNK1 NFIB VCAN PRR14L PLCG2 CTNND2 TRAPPC14 TNS1	4.82e-06	199	182	10	3780_DN
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	CDCA3 ZNF609 HIVEP2 DTNA GTSE1 ARHGEF12 PRC1 MKI67 PSRC1	1.51e-05	180	182	9	5027_DN
Drug	AC1NPPZW	ANK2 SPEG ADGRL1 NAV3 NAV2 NAV1 PKN1	1.93e-05	103	182	7	CID005183170
Drug	Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A	DENND2A PCGF2 GTSE1 ANOS1 MKI67 IQSEC1 WDFY3 AKAP1 PSRC1	2.05e-05	187	182	9	6764_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	ANK2 MAP4 LARP1 BRD4 VCAN WDFY3 TNS1 LRRC41 RASGRP2	2.13e-05	188	182	9	6186_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ABI3BP MAP4 GTSE1 APBB2 WNK1 RIN1 PRRC2C MSL3 KMT2A	2.42e-05	191	182	9	6020_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	ANK2 MAP4 DTNA UBAP2L DEPDC5 AKAP1 TNS1 LRRC41 RASGRP2	2.52e-05	192	182	9	2699_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	ZNF609 DTNA MEX3D GTSE1 BRD4 MKI67 PKN1 ANKRD40 PSRC1	2.52e-05	192	182	9	2865_DN
Drug	Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A	NIBAN1 PCGF2 ADAMTS3 SYNE1 SPTBN1 ADGRL1 ANOS1 MAST4 TNS1	2.63e-05	193	182	9	7059_DN
Drug	Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; PC3; HT_HG-U133A	ZNF609 PRR36 DTNA WNK1 LIG3 TLE1 VCAN KMT2A CTNND2	2.74e-05	194	182	9	6696_UP
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A	ZNF609 MAP4 POLH SPTBN1 MAST4 CELSR3 MAP1S HEY2 PATJ	2.74e-05	194	182	9	2864_DN
Drug	Xylazine [7361-61-7]; Down 200; 18.2uM; MCF7; HT_HG-U133A	ZNF609 PRR36 BRD3 ZBED4 SBF1 SYNJ1 NFIB PATJ PARD3	2.85e-05	195	182	9	4147_DN
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A	ZNF609 HIVEP2 MAP4 DTNA CHRNA4 SYNJ1 NFATC1 WDFY3 PARD3	2.85e-05	195	182	9	1156_UP
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	DENND2A PCGF2 NSD1 RIN1 LIG3 MAST4 MAP1S PLCG2 PATJ	2.85e-05	195	182	9	4533_DN
Drug	Metyrapone [54-36-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A	PCGF2 SPTBN1 APBB2 TLE1 WDFY3 TBR1 CTNND2 PATJ LRRC41	2.85e-05	195	182	9	5667_DN
Drug	Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; PC3; HT_HG-U133A	PCGF2 APBB2 ADGRL1 BRD3 MAST4 ZBED4 MARK2 TNS1 LRRC41	2.85e-05	195	182	9	6283_DN
Drug	Fendiline hydrochloride [13636-18-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A	PCGF2 BCORL1 ADGRL1 LIG3 SBF1 CNGB3 IQSEC1 TRAPPC14 PATJ	2.85e-05	195	182	9	7188_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	MAP4 DTNA BCORL1 APBB2 ARHGEF12 BAP1 CELSR3 IQSEC1 PATJ	2.85e-05	195	182	9	5329_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; HL60; HT_HG-U133A	POLH NSD1 GON4L RIN1 LIG3 ZBED4 OSBPL3 VCAN WDFY3	2.85e-05	195	182	9	1859_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A	NACA APBB2 ARHGEF12 MAST4 SBF1 BRD4 NAV3 PLCG2 WDFY3	2.85e-05	195	182	9	2122_DN
Drug	0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A	DTNA CD46 LIG3 SBF1 MSL3 NAV2 TRAPPC14 PARD3 MAP3K7	2.85e-05	195	182	9	7099_DN
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; HL60; HG-U133A	ZNF609 DTNA NACA AGPS BAP1 ZBED4 SBNO1 BRD1 AKAP1	2.97e-05	196	182	9	2031_DN
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	HIVEP2 WDR7 DTNA SBF1 TLE1 MSL3 KMT2A PLCG2 PARD3	2.97e-05	196	182	9	2775_DN
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A	ZNF609 DTNA ADGRL1 LIG3 NFIB TLE1 BRD4 PRR14L TRAPPC14	2.97e-05	196	182	9	1531_DN
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	PCGF2 MAP4 BCORL1 ADGRL1 LIG3 MAST4 CNGB3 TRAPPC14 SRRM2	2.97e-05	196	182	9	7187_DN
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	DTNA SPEG SPTBN1 APC2 WNK1 CELSR3 ARHGAP44 CNGB3 LRRC41	2.97e-05	196	182	9	5111_UP
Drug	Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A	MAP4 SPTBN1 APBB2 ADGRL1 WNK1 PRRC2C TLE1 PRR14L LRRC41	2.97e-05	196	182	9	4108_DN
Drug	Clioquinol [130-26-7]; Down 200; 13uM; PC3; HT_HG-U133A	ZNF609 INCENP BCORL1 CDC16 VCAN MSL3 WDFY3 ANKRD40 LRRC41	2.97e-05	196	182	9	4663_DN
Drug	Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A	ZNF609 MAP4 ARHGEF12 GON4L CD46 ANOS1 NFIB BRD4 MSL3	3.09e-05	197	182	9	1802_UP
Drug	Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A	WNK1 PTPRB TLE1 VCAN SYCP1 WDFY3 MAP3K7 TNS1 RASGRP2	3.09e-05	197	182	9	4803_UP
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ZNF609 MAP4 SPTBN1 NSD1 ARHGEF12 MAST4 MAP1S MSL3 PRR14L	3.09e-05	197	182	9	5360_UP
Drug	Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	MAP4 SPTBN1 ADGRL1 IQSEC1 PKN1 PLCG2 TRAPPC14 PATJ PARD3	3.09e-05	197	182	9	5343_DN
Drug	Methantheline bromide [53-46-3]; Down 200; 9.6uM; PC3; HT_HG-U133A	DENND2A PCGF2 POLH RIN1 SBF1 ZNF592 BRD4 VCAN MGRN1	3.09e-05	197	182	9	5780_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	PCGF2 PRR36 MAP4 SPTBN1 BCORL1 WNK1 MAP1S IQSEC1 MARK2	3.09e-05	197	182	9	1641_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ABI3BP ARHGEF12 MAST4 MAP1S MSL3 TRAPPC14 PATJ PARD3 LRRC41	3.09e-05	197	182	9	3515_DN
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A	HIVEP2 PRR36 MAP4 LIG3 MAST4 SBF1 NFIB TRAPPC14 PARD3	3.09e-05	197	182	9	1470_DN
Drug	Tobramycin [32986-56-4]; Down 200; 8.6uM; HL60; HT_HG-U133A	INCENP MAP4 DTNA SPTBN1 APBB2 CD46 LSM14A TRAPPC14 PARD3	3.09e-05	197	182	9	2481_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	DENND2A MAP4 ADGRL1 MAST4 NFATC1 VCAN MKI67 MARK2 SRRM2	3.09e-05	197	182	9	2070_DN
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	PRR36 MAP4 TEX2 ARHGEF12 ADGRL1 BAP1 BRD4 SRRM2 RASGRP2	3.09e-05	197	182	9	2766_UP
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A	PCGF2 MAP4 ZFP36 LIG3 ZNF592 PRR14L ASXL2 TRAPPC14 SRRM2	3.21e-05	198	182	9	1997_DN
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A	DTNA BCORL1 APBB2 BAP1 CELSR3 SBF1 SYNJ1 UBAP2L PATJ	3.21e-05	198	182	9	7204_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	ZNF609 MAP4 RIN1 LIG3 NFATC1 PKN1 TRAPPC14 PARD3 TNS1	3.21e-05	198	182	9	6189_DN
Drug	AH23848 hemicalcium salt hydrate; Down 200; 1uM; PC3; HT_HG-U133A	CACNB2 PCGF2 SPTBN1 APBB2 SBF1 CTNND2 TRAPPC14 PATJ TNS1	3.21e-05	198	182	9	6885_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	PCGF2 DTNA SPTBN1 ADGRL1 MAST4 SBF1 CNGB3 MORC3 TRAPPC14	3.21e-05	198	182	9	7177_DN
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A	ZNF609 HIVEP2 PRR36 DTNA POLH APBB2 MAST4 SBF1 PRR14L	3.21e-05	198	182	9	1534_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A	PCGF2 INCENP MAP4 PTPRB NFATC1 WDFY3 AKAP1 ANKRD40 RASGRP2	3.21e-05	198	182	9	1163_UP
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A	DTNA APBB2 GON4L WNK1 NFIB VCAN PRR14L CTNND2 ANKRD40	3.21e-05	198	182	9	4661_DN
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; HL60; HT_HG-U133A	ZNF609 PCGF2 HIVEP2 INCENP ADGRL1 SBF1 LSM14A TRAPPC14 RASGRP2	3.21e-05	198	182	9	2182_DN
Drug	topiramate; Up 200; 3uM; MCF7; HT_HG-U133A_EA	MAP4 BCORL1 APBB2 GON4L WNK1 LIG3 MAST4 NFIB PATJ	3.21e-05	198	182	9	915_UP
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	PCGF2 MAP4 DTNA POLH UBAP2L BRD4 PRR14L PARD3 ANKRD40	3.21e-05	198	182	9	3418_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	PCGF2 GON4L ADGRL1 WNK1 IGF2 SBF1 MARK2 TRAPPC14 SRRM2	3.21e-05	198	182	9	4592_DN
Drug	Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A	ZNF609 DTNA SPTBN1 BCORL1 APBB2 PTPRB VCAN CNGB3 MSL3	3.21e-05	198	182	9	7421_UP
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	INCENP DTNA CNNM1 SBF1 TLE1 LSM14A PATJ PARD3 LRRC41	3.34e-05	199	182	9	1466_DN
Drug	Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A	PCGF2 HIVEP2 MAP4 APBB2 ADGRL1 NFIB CNGB3 MSL3 MARK2	3.34e-05	199	182	9	5701_DN
Drug	Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	ZNF609 DTNA NACA LIG3 MAST4 CELSR3 CNGB3 PRR14L MARK2	3.34e-05	199	182	9	5302_DN
Drug	Phenindione [83-12-5]; Down 200; 18uM; PC3; HT_HG-U133A	PCGF2 MAP4 APBB2 ZFP36 RIN1 NFIB CDC16 MORC3 MGRN1	3.34e-05	199	182	9	7289_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; HL60; HT_HG-U133A	MAP4 CNNM1 LIG3 CELSR3 MAP1S OSBPL3 IQSEC1 PKN1 RASGRP2	3.34e-05	199	182	9	2442_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A	NIBAN1 INCENP DTNA RIN1 CELSR3 RIMS1 MARK2 PARD3 PRG4	3.34e-05	199	182	9	6492_UP
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A	MAP4 DTNA SPTBN1 ARHGEF12 WNK1 NFIB PRR14L MARK2 TNS1	3.34e-05	199	182	9	4334_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	HIVEP2 MAP4 SPTBN1 GON4L ADGRL1 MAP7D1 IQSEC1 CTNND2 PARD3	3.34e-05	199	182	9	1648_DN
Drug	Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ABI3BP SPEG SPTBN1 WNK1 ANOS1 SNCAIP NFIB VCAN WDFY3	3.47e-05	200	182	9	2224_UP
Drug	benzonitrile	TCF20 SYNE1 NSD1 WNK1	3.70e-05	24	182	4	CID000007505
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	ZNF609 HIVEP2 MAST4 OSBPL3 NAV2 PLEKHA5 LSM14A PARD3	7.25e-05	171	182	8	7535_DN
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CDCA3 MAP4 MEX3D GTSE1 LIG3 MKI67 PLEKHA5 PSRC1	8.87e-05	176	182	8	958_DN
Drug	5109870; Down 200; 25uM; MCF7; HT_HG-U133A_EA	CDCA3 ZNF609 GTSE1 PRC1 NFIB MKI67 ANKRD40 PSRC1	9.98e-05	179	182	8	904_DN
Drug	Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; PC3; HT_HG-U133A	PCGF2 MEX3D NACA ARHGEF12 CD46 ANOS1 ZBED4 SBNO1	9.98e-05	179	182	8	4651_DN
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	CDCA3 DTNA GTSE1 PRC1 BAP1 NFIB MKI67 PSRC1	1.25e-04	185	182	8	3241_DN
Drug	Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A	CDCA3 MAP4 GTSE1 PRC1 BRD4 MKI67 WDFY3 PSRC1	1.30e-04	186	182	8	5000_DN
Drug	Cocaine	MYO5A SYNE1 SPTBN1 NUP88 ADGRL1 CHRNA4 CRIP2 ZFPM2 CCND3 IGF2 SNCAIP PTPRB AMIGO3 CASTOR1 SNAP91 SBNO1 EGR2 BASP1 BRD4 ARHGAP44 PLEKHA5 SNTG2 CTNND2 EIF2AK3	1.34e-04	1314	182	24	ctd:D003042
Drug	Securinine [5610-40-2]; Down 200; 18.4uM; HL60; HT_HG-U133A	MAP4 DTNA APBB2 OSBPL3 TLE1 ARHGAP44 MSL3 RASGRP2	1.35e-04	187	182	8	2729_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A	PCGF2 HIVEP2 MAP4 DTNA APBB2 PLEKHA5 WDFY3 TRAPPC14	1.40e-04	188	182	8	1150_UP
Drug	Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; PC3; HT_HG-U133A	PCGF2 POLH RIN1 NAV3 LSM14A MARK2 TRAPPC14 LRRC41	1.45e-04	189	182	8	1832_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	NSD1 LIG3 DENND4B LSM14A PARD3 ANKRD40 LRRC41 RASGRP2	1.51e-04	190	182	8	1306_DN
Drug	Monobenzone [103-16-2]; Down 200; 20uM; HL60; HT_HG-U133A	MYBPH ZNF609 GTSE1 NFATC1 MKI67 IQSEC1 TRAPPC14 PSRC1	1.62e-04	192	182	8	3054_DN
Drug	Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A	MAP4 DTNA ARHGEF12 SBF1 PACS2 WDFY3 PARD3 TNS1	1.62e-04	192	182	8	6162_DN
Drug	Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A	MAP4 APBB2 SYNJ1 NFIB MARK2 TRAPPC14 PARD3 SRRM2	1.62e-04	192	182	8	2785_DN
Disease	neuroimaging measurement	CACNB2 KIF6 ADAMTS3 SPTBN1 ARHGEF12 POM121C NHSL1 ZNF469 IGF2 MAST4 CASTOR1 SYNJ1 SNAP91 SBNO1 NFIB PRRC2C DENND4B VCAN SYCP1 NAV3 NAV2 HEY2 ROBO2 PARD3 MAP3K7 TNS1 EIF2AK3 RAI1	6.32e-11	1069	178	28	EFO_0004346
Disease	brain measurement, neuroimaging measurement	CACNB2 KIF6 ADAMTS3 SPTBN1 NHSL1 MAST4 SBNO1 VCAN NAV3 NAV2 HEY2 ROBO2 PARD3 MAP3K7 TNS1	1.38e-06	550	178	15	EFO_0004346, EFO_0004464
Disease	Malignant neoplasm of breast	EVL KIF6 XIRP1 ANK2 SYNE1 POLH APC2 BCORL1 BCAR1 MAGEE1 PRC1 FOXA1 TTC3 WNK1 BAP1 SBNO1 SYNE2 MKI67 HEY2 BOD1L1 TNS1	2.31e-06	1074	178	21	C0006142
Disease	Intellectual Disability	PCGF2 HIVEP2 TCF20 SYNE1 APC2 NSD1 GON4L NFIB BRD4 MSL3 IQSEC1 PACS2 RAI1	3.58e-06	447	178	13	C3714756
Disease	cortical thickness	KIF6 ADAMTS3 SPTBN1 ARHGEF12 NHSL1 ZNF469 IGF2 MAST4 SNAP91 IGHA2 VCAN NAV3 NAV2 NAV1 KMT2A ROBO2 LSM14A PARD3 MAP3K7 TNS1	1.40e-05	1113	178	20	EFO_0004840
Disease	cortical surface area measurement	KIF6 ADAMTS3 SPTBN1 ARHGEF12 NHSL1 ZNF469 IGF2 MAST4 ARHGAP31 NFIB PRRC2C VCAN MDC1 NAV3 NAV2 HEY2 NAV1 ROBO2 BRD1 PARD3 MAP3K7 TNS1	2.18e-05	1345	178	22	EFO_0010736
Disease	Adenoid Cystic Carcinoma	BCORL1 NSD1 NFIB VCAN MARK2 BRD1	3.30e-05	100	178	6	C0010606
Disease	mean platelet volume	NIBAN1 HIVEP2 MYO5A TEX2 SPTBN1 NACA BCORL1 NUP88 BRD3 PRC1 ZFPM2 MAST4 ZBED4 NFATC1 SYNE2 BIN2 PLCG2 BRD1	4.88e-05	1020	178	18	EFO_0004584
Disease	teratocarcinoma-derived growth factor 1 measurement	MYO5A KMT2A TNS1	1.14e-04	16	178	3	EFO_0008297
Disease	Global developmental delay	PCGF2 TCF20 APC2 NFIB IQSEC1 PACS2	1.61e-04	133	178	6	C0557874
Disease	Brugada syndrome	ZFPM2 HEY2 HERPUD2	1.95e-04	19	178	3	MONDO_0015263
Disease	Autistic Disorder	NSD1 CHRNA4 IGF2 EGR2 ROBO2 SNTG2 RIMS1 TBR1	1.97e-04	261	178	8	C0004352
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	2.15e-04	4	178	2	cv:CN293514
Disease	Sotos' syndrome	APC2 NSD1	2.15e-04	4	178	2	C0175695
Disease	obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa	CACNB2 TCF20 SNAP91 OSBPL3 SYNE2 IGSF9B RIMS1	2.22e-04	200	178	7	EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Disease	Neurodevelopmental Disorders	ANK2 KMT2A RIMS1 WDFY3 TBR1	2.56e-04	93	178	5	C1535926
Disease	level of Sphingomyelin (d40:2) in blood serum	ADAMTS3 NUP88 SYNE2	3.50e-04	23	178	3	OBA_2045181
Disease	Weaver syndrome	NSD1 KMT2A	3.58e-04	5	178	2	C0265210
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	3.58e-04	5	178	2	C1450051
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE1 SYNE2	3.58e-04	5	178	2	C0410190
Disease	brain glioma (is_marker_for)	FOXA1 PTPRB	3.58e-04	5	178	2	DOID:0060108 (is_marker_for)
Disease	Colorectal Carcinoma	EVL CACNB2 ANK2 SYNE1 APC2 CD46 WNK1 LIG3 IGF2 NFATC1 MKI67 ACTL9 CTNND2	3.58e-04	702	178	13	C0009402
Disease	Brugada Syndrome (disorder)	CACNB2 ANK2 HEY2	3.98e-04	24	178	3	C1142166
Disease	electrocardiography	CACNB2 SPEG SPTBN1 ZFPM2 LIG3 MAST4 ZNF592 NAV2 HEY2 PROB1 HERPUD2	3.98e-04	530	178	11	EFO_0004327
Disease	cortical surface area measurement, neuroimaging measurement	ADAMTS3 SPTBN1 NHSL1 VCAN NAV3 NAV2 MAP3K7	4.77e-04	227	178	7	EFO_0004346, EFO_0010736
Disease	retinal layer thickness measurement	CDCA3 KIF6 SNAP91 ROBO2	4.80e-04	60	178	4	EFO_0600002
Disease	Acute monocytic leukemia	BLM KMT2A SLX4	5.07e-04	26	178	3	C0023465
Disease	Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	5.34e-04	6	178	2	cv:C0410189
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE1 SYNE2	5.34e-04	6	178	2	C0410189
Disease	Hyperplasia	ZFP36 BRD4 PRG4	6.33e-04	28	178	3	C0020507
Disease	white matter microstructure measurement	CACNB2 MAST4 CASTOR1 NFATC1 VCAN NAV2 ROBO2 ASXL2 WDFY3	6.37e-04	390	178	9	EFO_0005674
Disease	Beckwith-Wiedemann Syndrome	NSD1 IGF2	7.45e-04	7	178	2	C0004903
Disease	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	CHRNA4 DEPDC5	7.45e-04	7	178	2	C3696898
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	7.45e-04	7	178	2	C0751337
Disease	brain connectivity measurement	KIF6 GTSE1 NHSL1 VCAN NAV3 NAV2 HEY2 ROBO2 MAP3K7	7.62e-04	400	178	9	EFO_0005210
Disease	JT interval	CACNB2 NACA ZFPM2 LIG3 HEY2 HERPUD2 RAI1	8.04e-04	248	178	7	EFO_0007885
Disease	age-related hearing impairment	DENND2A SPTBN1 NSD1 TUB ZFPM2 CASTOR1 SNAP91 PRR14L	8.24e-04	324	178	8	EFO_0005782
Disease	mean arterial pressure	CACNB2 NIBAN1 TCF20 MAP4 WDR7 ARHGEF12 BCAR1 POM121C KIAA1217 TNS1	9.51e-04	499	178	10	EFO_0006340
Disease	Abnormality of the skeletal system	PCGF2 APC2	9.89e-04	8	178	2	C4021790
Disease	Attached earlobe	HIVEP2 KIAA1217	9.89e-04	8	178	2	HP_0009907
Disease	Cornelia De Lange Syndrome	BRD4 KMT2A	9.89e-04	8	178	2	C0270972
Disease	joint hypermobility measurement	ABI3BP VCAN ARHGAP44	1.03e-03	33	178	3	EFO_0007905
Disease	Liver carcinoma	CDCA3 GTSE1 PRC1 ZFP36 IGF2 CELSR3 EGR2 MKI67 KMT2A DEPDC5	1.07e-03	507	178	10	C2239176
Disease	retinal vasculature measurement	CDCA3 MYO5A SPTBN1 MUC12 NIBAN2 IQSEC1 NAV3 SNTG2 PATJ TNS1	1.24e-03	517	178	10	EFO_0010554
Disease	schizophrenia, intelligence, self reported educational attainment	CACNB2 MAP4 BRD3 SNAP91 EGR2 NFIB KMT2A IGSF9B	1.25e-03	346	178	8	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	pyruvate measurement	ZFPM2 NFIB TLE1 KIAA1217 NAV3 PACS2 CTNND2	1.26e-03	268	178	7	EFO_0010117
Disease	urticaria, response to non-steroidal anti-inflammatory, angioedema	ABI3BP RIMS1	1.27e-03	9	178	2	EFO_0005531, EFO_0005532, EFO_0005533
Disease	synaptotagmin-11 measurement	GON4L ZFPM2	1.27e-03	9	178	2	EFO_0802108
Disease	venous thromboembolism, factor VII measurement	ZFPM2 PLCG2 PARD3	1.56e-03	38	178	3	EFO_0004286, EFO_0004619
Disease	optic disc size measurement	DENND2A KIF6 ABI3BP VCAN NAV3 NAV1	1.58e-03	205	178	6	EFO_0004832
Disease	tauopathy (implicated_via_orthology)	EVL MAP4	1.58e-03	10	178	2	DOID:680 (implicated_via_orthology)
Disease	CXCL5 measurement	BRD3 ZFPM2	1.58e-03	10	178	2	EFO_0009422
Disease	C-X-C motif chemokine 5 measurement	BRD3 ZFPM2	1.58e-03	10	178	2	EFO_0008058
Disease	body surface area	ADAMTS3 NSD1 ARHGEF12 WNK1 CCND3 MAP7D1 IGF2 HEY2 PATJ PARD3 EIF2AK3	1.90e-03	643	178	11	EFO_0022196
Disease	brain-derived neurotrophic factor measurement	BRD3 ZFPM2	1.92e-03	11	178	2	EFO_0011018
Disease	Ductal Carcinoma	BCAR1 FOXA1	1.92e-03	11	178	2	C1176475
Disease	eye color	APBB2 MUC16 TTC3 EFCAB7	2.18e-03	90	178	4	EFO_0003949
Disease	suicide behaviour measurement	CNTN5 MKI67 CTNND2	2.23e-03	43	178	3	EFO_0006882
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE1 SYNE2	2.30e-03	12	178	2	DOID:11726 (implicated_via_orthology)
Disease	tumor necrosis factor receptor superfamily member EDAR measurement	BRD3 ZFPM2	2.30e-03	12	178	2	EFO_0008310
Disease	autism spectrum disorder (implicated_via_orthology)	TCF20 RIMS1 WDFY3 TBR1 CTNND2	2.34e-03	152	178	5	DOID:0060041 (implicated_via_orthology)
Disease	coronary artery disease	HIVEP2 ADAMTS3 ARHGEF12 BCAR1 TUB ZFPM2 MAST4 MAP1S CASTOR1 BASP1 NFIB KIAA1217 PLCG2 TNS1 PSRC1 RAI1	2.46e-03	1194	178	16	EFO_0001645
Disease	white matter hyperintensity measurement	EVL CACNB2 ANK2 GON4L IGF2 SNCAIP VCAN	2.47e-03	302	178	7	EFO_0005665
Disease	diastolic blood pressure, systolic blood pressure	CACNB2 ANK2 ADAMTS3 SPEG TERF2 PIAS1 KIAA1671 LIG3 BRD4 NAV1 HERPUD2	2.61e-03	670	178	11	EFO_0006335, EFO_0006336
Disease	unipolar depression, bipolar disorder	SYNE1 OSBPL3 CNTN5 SYNE2 MARK2	2.62e-03	156	178	5	EFO_0003761, MONDO_0004985
Disease	Brugada Syndrome 1	CACNB2 HEY2	2.70e-03	13	178	2	C4551804
Disease	Charcot-Marie-Tooth disease type 4	SBF1 EGR2	2.70e-03	13	178	2	cv:C4082197
Disease	tetralogy of Fallot (implicated_via_orthology)	ZFPM2 HEY2	3.14e-03	14	178	2	DOID:6419 (implicated_via_orthology)
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	ADAMTS3 PSRC1	3.14e-03	14	178	2	EFO_0004611, EFO_0008589
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	CACNB2 SYNE1 ZFPM2 KMT2A	3.32e-03	101	178	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	obsolete_red blood cell distribution width	C19orf47 LARP1 CD46 BRD3 PRC1 WNK1 ZFPM2 CCND3 MAST4 PRRC2C KIAA1217 BRD4 CNTN5 SYNE2 HSH2D LSM14A ASXL2	3.35e-03	1347	178	17	EFO_0005192
Disease	cognitive inhibition measurement	CACNB2 HIVEP2 TCF20	3.44e-03	50	178	3	EFO_0007969
Disease	Weight Gain	MAP4 SPTBN1 APBB2 ARHGEF12	3.44e-03	102	178	4	C0043094
Disease	Alopecia, Male Pattern	ZFP36 BRD4	3.61e-03	15	178	2	C4083212
Disease	Androgenetic Alopecia	ZFP36 BRD4	3.61e-03	15	178	2	C0162311
Disease	Female pattern alopecia (disorder)	ZFP36 BRD4	3.61e-03	15	178	2	C0263477
Disease	lung non-small cell carcinoma (is_marker_for)	BCORL1 FOXA1 PTPRB MKI67 IQSEC1	3.69e-03	169	178	5	DOID:3908 (is_marker_for)
Disease	QRS-T angle	SPEG SPTBN1 NACA KMT2A	3.94e-03	106	178	4	EFO_0020097
Disease	Leukemia, Myelocytic, Acute	NSD1 BLM KMT2A ASXL2 SLX4	4.07e-03	173	178	5	C0023467
Disease	Cardiovascular Abnormalities	PCGF2 APC2	4.11e-03	16	178	2	C0243050
Disease	Abnormal behavior	BCORL1 IQSEC1	4.11e-03	16	178	2	C0233514
Disease	body weight	CACNB2 HIVEP2 ADAMTS3 NUP88 ARHGEF12 GON4L POM121C CCND3 MAP7D1 MAST4 CDC16 KIAA1217 HEY2 PATJ MAP3K7 EIF2AK3	4.18e-03	1261	178	16	EFO_0004338
Disease	corneal topography	ADAMTS3 NHSL1 ZNF469 IGF2	4.36e-03	109	178	4	EFO_0004345
Disease	leukemia	BAP1 BLM KMT2A	4.50e-03	55	178	3	C0023418
Disease	HOMA-B	SPTBN1 ZFPM2 NAV3	4.50e-03	55	178	3	EFO_0004469
Disease	level of Sphingomyelin (d32:1) in blood serum	NUP88 SYNE2	4.64e-03	17	178	2	OBA_2045173
Disease	MHPG measurement, 5-HIAA measurement	CCND3 ROBO2	4.64e-03	17	178	2	EFO_0005132, EFO_0005133
Disease	pathological myopia	SPTBN1 CNTN5 NAV3 CTNND2	4.65e-03	111	178	4	EFO_0004207
Disease	diet measurement	TCF20 ZFPM2 ZNF469 EGR2 CDC16 KIAA1217 DENND4B CNTN5 ROBO2 DEPDC5 IGSF9B RIMS1 PLCG2 CTNND2	4.70e-03	1049	178	14	EFO_0008111
Disease	cup-to-disc ratio measurement	KIF6 ABI3BP SNCAIP TCP11L2 VCAN NAV2 KMT2A MARK2	4.75e-03	430	178	8	EFO_0006939
Disease	Adrenocortical carcinoma	BAP1 IGF2	5.20e-03	18	178	2	C0206686
Disease	irritable bowel syndrome symptom measurement	NFIB NAV2 CTNND2	5.22e-03	58	178	3	EFO_0021536
Disease	myocardial infarction	BCAR1 ZFPM2 CASTOR1 PLCG2 HERPUD2 TNS1 PSRC1	5.52e-03	350	178	7	EFO_0000612
Disease	Lewy body dementia (is_marker_for)	CHRNA4 IGF2	5.78e-03	19	178	2	DOID:12217 (is_marker_for)
Disease	Pseudopelade	ZFP36 BRD4	5.78e-03	19	178	2	C0086873
Disease	Alopecia	ZFP36 BRD4	5.78e-03	19	178	2	C0002170

Protein segments in the cluster

Peptide	Gene	Start	Entry
ETQAPTSLATKDPPS	PI16	261	Q6UXB8
SPSATVKTRSTKAPP	CHRNA4	541	P43681
PSSPCSVKHSPTRET	BRD1	16	O95696
PTTSAITASRSESPP	BRD3	251	Q15059
TETSSSPRDKAITPP	AKAP1	521	Q92667
PTSTATSRSPPESKG	CFAP54	26	Q96N23
RKGSLSSVTPSPTPE	APBB2	331	Q92870
REASQTSSSPAPKAP	CCND3	256	P30281
ESTEPSASSKLPPAL	VCAN	816	P13611
KSSSEATLSISPPRP	EIF2AK3	846	Q9NZJ5
PPRRPDTSTSKISVT	C19orf47	156	Q8N9M1
PTKVVAPPSSSDSSS	BRD4	476	O60885
TDKTSSIQSRPLPSP	BCAR1	626	P56945
TPKEAASSSPEPSSI	CASTOR1	211	Q8WTX7
TARPTPLTSTASPAA	ADGRL1	416	O94910
PTEPCTPSKSRSASS	BCORL1	1456	Q5H9F3
PKSSESQSSLEAPRP	ACTL9	6	Q8TC94
PTRPSSPVTSHISKV	BAP1	516	Q92560
PTEISLSSKPRAPRT	ANGPTL3	211	Q9Y5C1
SAPSAILRTPESTKP	ANKRD40	191	Q6AI12
APSPATTASPAKVDS	SNAP91	621	O60641
LSTTPPDAPSRKASV	AMIGO3	436	Q86WK7
KSQEEVLPSSTTPSP	BIN2	356	Q9UBW5
PVPDQPSSASEKTSS	CTNND2	16	Q9UQB3
PNPSASSKTDASVPV	ASXL2	866	Q76L83
SSLGDIVPSSRKSTP	CACNB2	206	Q08289
IVPSSRKSTPPSSAI	CACNB2	211	Q08289
STPSSVSPEPQDSAK	ARHGEF12	631	Q9NZN5
TPVASQSSDKPSRDP	CDCA3	161	Q99618
PSSEVSATTKKSPPS	CNTN5	961	O94779
SPSVAQKSELPPRTS	NKD1	276	Q969G9
PKPHRKPSSSASSSS	RAI1	1621	Q7Z5J4
DKPSPVTSPSSSPSV	NSD1	2331	Q96L73
KPLFSSASPQDSSPR	NFIB	321	O00712
SKSEERPSSPDTSTP	RIMBP3B	306	A6NNM3
SKSEERPSSPDTSTP	RIMBP3C	306	A6NJZ7
RKSSAPSASVPAPST	EGR2	426	P11161
SPSPSTPESATLSEK	NIBAN2	601	Q96TA1
SPVSSTKTERHPPVS	ANK2	1891	Q01484
SSSPSLPSRTLPTEE	DEPDC5	501	O75140
ESTPCRLSTTSEVPP	HEY2	206	Q9UBP5
TIKTFRTPELPPSSA	ANOS1	646	P23352
PVSSPTEPTARRKSS	MUC16	3126	Q8WXI7
STIARSLPTTVPESP	LARP1	761	Q6PKG0
NKVTAESRTAPSPPS	PTPRB	1251	P23467
SASSRPGVSATPPKS	MAP1S	931	Q66K74
PVTPKPTSQATRSRT	MDC1	1136	Q14676
TSTDQPVTPKPTSRT	MDC1	1336	Q14676
TLVPTAPKLEPSTST	MDC1	1406	Q14676
RNTSRPPTSSEEPST	MAGEE1	136	Q9HCI5
SRPSTTPFIDKKPTS	MAP4	896	P27816
TTKSPASSASGPRPT	CD46	306	P15529
PDSSATSTRKQPPSS	KIAA1671	1556	Q9BY89
SVFPPRKNPVTSSTS	NEDD1	441	Q8NHV4
SLQREPRSKSSPTSP	RASGRP2	381	Q7LDG7
PRSKSSPTSPTSCTP	RASGRP2	386	Q7LDG7
SKTPSSPCPASKVVR	INCENP	476	Q9NQS7
KASSTSDPPALPDST	MUC20	451	Q8N307
PQSKAPDSTLRSPSS	MGRN1	446	O60291
DLSEPTTLKSPAPSS	IQSEC1	216	Q6DN90
KSEPSSPRLASSPVQ	ZFPM2	471	Q8WW38
PSSKETPAATEAPSS	BASP1	181	P80723
TPAATEAPSSTPKAQ	BASP1	186	P80723
SPSTTPLPDSSPSRK	NHSL1	1181	Q5SYE7
LSTPSFSSPKESVPR	MORC3	496	Q14149
TGNTAKPTRPPSESS	NAV3	1856	Q8IVL0
SRTPSVAKSPEAKSP	EVL	341	Q9UI08
TTSGPTSEKPTRSHP	MAP3K7	466	O43318
SRSSSPIPLTPSKEG	MSL3	396	Q8N5Y2
PSSKRSPSTATLSLP	NFATC1	146	O95644
SENSRKPPSASSAPA	MEX3D	581	Q86XN8
STSTPLEDSIPKRPV	KIF6	766	Q6ZMV9
SPVSTRPLPSASQKA	LSM14A	216	Q8ND56
CKSPPPELTDTATST	MKI67	2586	P46013
TKPTEASADQLPSPS	PLCG2	431	P16885
FPASKSPASSPLTRS	PSRC1	181	Q6PGN9
TFKSRPSLAPPAASS	GGN	246	Q86UU5
AKEASPTPPSSPSVS	PACS2	716	Q86VP3
SGEAPSSPTPKRSLS	LIG3	236	P49916
SPDSSTPKLSRAQRP	GTSE1	461	Q9NYZ3
ITTKEATSSCPPKSP	HSH2D	181	Q96JZ2
EPSTLTPSSALKPSD	SBF1	1101	O95248
SPASSRSQTPERPAK	POM121C	416	A8CG34
AETATKPQATSAPSP	POM121C	661	A8CG34
LSSDQSESVRPSPPK	RIMS1	501	Q86UR5
DKAPSPATLPATSSS	PCGF2	261	P35227
ASELKTPASSTAPPI	FOXA1	346	P55317
SAPPEAESPLASTSK	BOD1L1	2196	Q8NFC6
SATPPARLAKTPSSS	APC2	1861	O95996
TPLETSRKTPDSRPS	CDC16	581	Q13042
TVPSSPPTKRVHLSS	ADAMTS3	1146	O15072
TPSSSPDDKLLTSPR	KLHL14	106	Q9P2G3
TNTVKTDLPPPSSES	BLM	201	P54132
LGSPSSLSSSKPREP	C5orf60	186	A6NFR6
FPASPTSSIPDTLTK	DENND2A	401	Q9ULE3
STPSESPRTKKFPLT	EFCAB7	16	A8K855
TPAKSERDVSTPPTV	IGF2	86	P01344
EPPASFLSPVSSKTR	GON4L	2046	Q3T8J9
KPRPSADLTNSSAPS	MARK2	376	Q7KZI7
ASELSPKSKARPSSP	MAP7D1	456	Q3KQU3
SKTELPSPESAQSPS	MAST4	1816	O15021
QTLDSRPSVPSPKSA	DENND4B	1201	O75064
SSGSPFITRSSPPKD	DTNA	356	Q9Y4J8
PRKQTSAPAEPFSSS	KMT2A	816	Q03164
ASPTSPKVFPLSLDS	IGHA2	1	P01877
PPSSPKSSTNRESHE	HERPUD2	91	Q9BSE4
APRAARKASPSPSSA	CCDC177	201	Q9NQR7
SLPSRQTAPTKPTES	CCDC168	4731	Q8NDH2
PPKGPSRASSVTTFT	CRIP2	106	P52943
RPSPSEVLPTSSSIE	CELSR3	2371	Q9NYQ7
SPIQPALDPSRSKSS	S1PR3	326	Q99500
SKRPSFSSTPVISPA	SBNO1	811	A3KN83
DPSSKSLLPPTDTRF	OSBPL3	796	Q9H4L5
SAPTRLEPETAPTKS	PRR14L	1571	Q5THK1
SKPSPVDSNRSTPSN	PARD3	1136	Q8TEW0
PTEAEKPASSSLPSS	NUP88	36	Q99567
ALPSRRDGTPTKTTP	NYAP1	306	Q6ZVC0
SPPEDRTVKDSTPSS	NAV1	1826	Q8NEY1
KVRVSTETSSPLSPP	RIN1	246	Q13671
GSRSSPEPKTKSRTP	SRRM2	1671	Q9UQ35
SLKPSAVPEPSSFTT	TATDN2	351	Q93075
SPADTPVSESSSPLK	TBR1	641	Q16650
SKSSSPASTSPPRVV	TCP11L2	46	Q8N4U5
DSIVSSETPSPPSKR	SYNE1	156	Q8NF91
VSVVDSSPASSPPAK	SYNE2	156	Q8WXH0
SPPVDPFTTLASKAS	SYNJ1	1551	O43426
APGTKRSPSAPAATS	LRRC41	351	Q15345
KKSALEPSSSTPRAP	NKX6-3	196	A6NJ46
SKSEERPSSPDTSTP	RIMBP3	306	Q9UFD9
SSPLATPSPSGTKAR	PRR36	301	Q9H6K5
TLSESPLSSPAASPK	NAV2	1476	Q8IVL1
SRLPPSGSKPVAAST	PRC1	516	O43663
KPSPATVRSTDPVTT	PRRC2C	2141	Q9Y520
EPPTSIPSASRKGSS	KIAA1217	1726	Q5T5P2
PSPDSTAAQKVATSP	SNCAIP	781	Q9Y6H5
TASTATKPAPPSEDV	MYBPH	56	Q13203
TSFLSSDPSSLPKVP	POLH	441	Q9Y253
SDPSSLPKVPVTSSE	POLH	446	Q9Y253
TTAPSSPSSPIAKDP	SNTG2	196	Q9NY99
SSPQKSSRDPPSSPS	PKN1	561	Q16512
SAKRTCPSLSPTSPL	PIAS1	476	O75925
ARKLSPEAPAPSSAT	PROB1	256	E7EW31
PSVFTSTLSKSRPTP	ARHGAP44	716	Q17R89
RPSLPPNSDTSKETS	PRG4	261	Q92954
PRPSSTKSTPASQVY	SERPINA9	31	Q86WD7
SCLTTAVPSPSKPRT	SLX4	191	Q8IY92
EQRTSSKESSPIPSP	SPTBN1	2156	Q01082
SKESSPIPSPTSDRK	SPTBN1	2161	Q01082
SKASLNPSDTPPSVV	AGPS	146	O00116
SSPEASPQTAKPTAV	CNGB3	156	Q9NQW8
DSTKAPTTRGTPQTP	CNNM1	811	Q9NRU3
APAPVSTAPATKTSR	TNRC18	2011	O15417
ATATSSPPPKARSNE	FYTTD1	11	Q96QD9
STPVLKSSTPTPRSD	TLE1	311	Q04724
DPKDTPSQPSSTSHR	WDFY3	3296	Q8IZQ1
SAVKSDSPSTSSIPP	UBAP2L	641	Q14157
PSESVSSLTDLKPPT	NIBAN1	576	Q9BZQ8
FSRPSTPKTSRAVSP	SPEG	536	Q15772
PSTPKSAEPSATTPS	SPEG	2186	Q15772
KEVVSSPGSSPRSSP	SPEG	2936	Q15772
PVSEKPSASRTSIPV	SRCIN1	1156	Q9C0H9
SKESDPSQSTVPRSP	SRRM5	636	B3KS81
QPSKPTSTVLPRSAS	SOWAHA	101	Q2M3V2
EARPLSRKSSPSSPA	TRAPPC14	486	Q8WVR3
PPAAVSFSRKSTPST	IGSF9B	1241	Q9UPX0
RRKTSSSTSPLEPPS	PATJ	451	Q8NI35
VPPRSSSSQVSAVKP	SYCP1	11	Q15431
SASAARPDLPPVTKS	PLCH2	1186	O75038
PPATSVAARSSSLPS	ZNF592	946	Q92610
PLLSPKEATSDPSRT	TNS1	846	Q9HBL0
PTSPTATSTTPSRYK	ZFP36	91	P26651
PPASSTSEDVKASPS	ZNF609	421	O15014
PDVKSKPVSDSSSAP	TTC3	1216	P53804
SKTVRTTEEAPSAPP	ROBO2	726	Q9HCK4
PPSSTVTDSKVLLSP	ARHGAP31	1361	Q2M1Z3
GQRSLTPPPSSTESK	TCF20	1666	Q9UGU0
SVAQKPRPSSPAVTS	nan	101	Q1RN00
SETATTPAKPSFPSR	ZNF469	3731	Q96JG9
VPSPATTTTTKAPRL	ZNF598	726	Q86UK7
SAVTKPSSSVTPRHP	ZC3H7A	421	Q8IWR0
PKDPAALGSSRSSPS	nan	226	A8MUI8
PPVPRISVKTSASAS	VXN	116	Q8TAG6
PAPSTVPSSTSKDRP	WNK1	151	Q9H4A3
VPSSTSKDRPVSQPS	WNK1	156	Q9H4A3
SSSSPESTLVKPEPN	WNK1	1896	Q9H4A3
KTAPSSPLTSPSDTR	TEX2	261	Q8IWB9
TPETVPRSTKPTTSS	ABI3BP	331	Q7Z7G0
PRAKSPTPESSTIAS	PLEKHA5	851	Q9HAU0
VKSLSPSPESSASPV	PLEKHA5	1086	Q9HAU0
DLTPKTRSRSTSPQP	HIVEP2	1926	P31629
SRTQASSSPAALKPP	UHRF1BP1	981	Q6BDS2
TPDLSKARGSPPTSS	WDR7	926	Q9Y4E6
KSVREAASAPSPTAP	TUB	226	P50607
PSSRDSPSSPTFISI	XIRP1	1661	Q702N8
SSQEAASAPPSKPTV	TERF2	421	Q15554
SLTTRPSESKTPSPQ	VWA5B1	1091	Q5TIE3
TLRFSPSPPKSADAS	UTF1	201	Q5T230
SVSSSPVKPVRESPS	ZBED4	371	O75132
PAPSRKASAASASPR	GARIN5B	476	Q8N5Q1
PSSKDTRPAPPTTTS	MUC12	781	Q9UKN1
SPRSPDATLSPATTT	MUC12	1446	Q9UKN1
SPRSPDATLSPATTT	MUC12	4086	Q9UKN1
TPKEAPATPSSKEAS	NACA	1566	E9PAV3
SSGRTPLTRTPAKPT	MYO5A	606	Q9Y4I1